{"content":"<li class=\"n-box-item date-title\" data-end=\"1512622799\" data-start=\"1512536400\" data-txt=\"Monday, December 23, 2019\">Wednesday, December  6, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3316812\" data-ts=\"1512605355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316812-broadcomplus-4_4-wireless-chips-drive-q4-beat-strong-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom +4.4% as wireless chips drive Q4 beat, strong guidance</a></h4><ul>   <li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) is <font color='green'>up 4.4%</font> in after-hours trade following <a href=\"https://seekingalpha.com/news/3316750-broadcom-beats-0_07-beats-revenue\" target=\"_blank\">fiscal Q4 earnings</a> where it beat the Street thanks to healthy demand for wireless chips spurred by smartphones.</li>    <li>As <a href=\"https://seekingalpha.com/news/3316720-broadcom-near-flat-ahead-earnings-credit-suisse-bullish\" target=\"_blank\">Credit Suisse noted earlier today</a>, one watchword was guidance, and (based in part on its Brocade acquisition) Broadcom forecast Q1 net revenues of $5.225B-$5.375B, well above consensus for $4.836B.</li>    <li>It's also boost its long-term free cash flow target to 40% of net revenue, from 35%.</li>    <li>Net income came to $636M, vs. a loss of $632M a year ago.</li>    <li>Gross margin was $2.383B (49.2% of net revenue). operating income was $865M (17.9% of net revenue).</li>    <li>Revenue by segment: Wired infrastructure, $2.146B (up 3%); Wireless communications, $1.796B (up 33%); Enterprise storage, $645M (up 15%); Industrial and other, $257M (up 66%).</li>    <li>Cash and short-term investments came to $11.2B, vs. the previous quarter's $5.449B. It got $1.959B in cash from operations and $3.98B from issuing long-term debt, along with $440M from sale of real property.</li>    <li>Broadcom says it will continue to target long-term annual revenue growth of 5%, but raise its target for non-GAAP gross margin to  65% and for non-GAAP operating margin to 47.5%.</li>    <li><a href=\"https://seekingalpha.com/article/4130215-broadcom-limited-2017-q4-results-earnings-call-slides\" target=\"_blank\">Earnings slides</a></li>    <li><a href=\"https://seekingalpha.com/pr/17020475-broadcom-limited-announces-fourth-quarter-fiscal-year-2017-financial-results-interim-dividend\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3316812\" data-linked=\"Broadcom +4.4% as wireless chips drive Q4 beat, strong guidance\" data-tweet=\"$AVGO - Broadcom +4.4% as wireless chips drive Q4 beat, strong guidance https://seekingalpha.com/news/3316812-broadcomplus-4_4-wireless-chips-drive-q4-beat-strong-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3316812-broadcomplus-4_4-wireless-chips-drive-q4-beat-strong-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316804\" data-ts=\"1512600205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPW\" target=\"_blank\">DPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316804-digital-power-denies-rumors-of-amazon-cryptocurrency-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Power denies rumors of Amazon cryptocurrency deal</a></h4><ul>     <li>Digital Power (NYSEMKT:<a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a>) finished <font color='red'>-24%</font> in today's trade after rising as much as 41%, as it <a href=\"https://seekingalpha.com/pr/17020517-digital-power-corporation-denies-rumors-regarding-amazon\" target=\"_blank\">denies rumors</a> of an agreement with Amazon for $450M in cryptocurrency hardware.</li>     <li>\"While DPW has made moves towards entering the cryptocurrency and digital mining spaces and has disclosed its activities in recent press releases and will continue to do so, DPW categorically denies the validity and  accuracy of any such rumors,\" the company says.</li>     <li>DPW&nbsp;<font color='green'>+13.8%</font> after-hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316804\" data-linked=\"Digital Power denies rumors of Amazon cryptocurrency deal\" data-tweet=\"$DPW - Digital Power denies rumors of Amazon cryptocurrency deal https://seekingalpha.com/news/3316804-digital-power-denies-rumors-of-amazon-cryptocurrency-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3316804-digital-power-denies-rumors-of-amazon-cryptocurrency-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316802\" data-ts=\"1512599780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316802-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a> <font color='green'>+23.9%</font>. <a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a> <font color='green'>+11.3%</font>. <a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a> <font color='green'>+7.4%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+6.6%</font>. <a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a> <font color='green'>+4.8%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='red'>-7.1%</font>. <a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a> <font color='red'>-5.3%</font>. <a href='https://seekingalpha.com/symbol/KFY' title='Korn/Ferry International'>KFY</a>&nbsp;<font color='red'>-4.3%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a> <font color='red'>-3.7%</font>. <a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies Inc.'>KEYS</a> <font color='red'>-2.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316802\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SEAC $TLRD $CMTL - After Hours Gainers / Losers https://seekingalpha.com/news/3316802-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3316802-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316779\" data-ts=\"1512596442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEYS\" target=\"_blank\">KEYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316779-keysightminus-4_5-on-q4-beats-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keysight -4.5% on Q4 beats, downside guidance</a></h4><ul><li>        Keysight (NYSE:<a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies Inc.'>KEYS</a>) shares are&nbsp;<font color='red'>down 4.5%</font>&nbsp;aftermarket following Q4 results that beat EPS estimates and missed on revenue. Q1 guidance has revenue from $780M to $820M (consensus: $864.09M) and EPS from $0.29 to $0.43 (consensus: $0.61).</li><li>               1H18 guidance has revenue at $1.775B ($1.76B consensus) and EPS at $1.29 ($1.28 consensus).&nbsp;</li><li>               Seasonality of revenue will be impacted for a few quarters since Keysight&rsquo;s headquarters were under mandatory evacuation for three weeks due to the California wildfires. &nbsp;&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17020469-keysight-technologies-reports-fourth-quarter-fiscal-2017-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316752-keysight-beats-0_07-misses-revenue\" target=\"_blank\">Keysight beats by $0.07, misses on revenue</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316779\" data-linked=\"Keysight -4.5% on Q4 beats, downside guidance\" data-tweet=\"$KEYS - Keysight -4.5% on Q4 beats, downside guidance https://seekingalpha.com/news/3316779-keysightminus-4_5-on-q4-beats-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3316779-keysightminus-4_5-on-q4-beats-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316767\" data-ts=\"1512595424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLLI\" target=\"_blank\">OLLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316767-solid-quarter-posted-ollies-bargain-outlet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid quarter posted by Ollie&#39;s Bargain Outlet</a></h4><ul>     <li>Ollie's Bargain Outlet Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OLLI' title='Ollie&#39;s Bargain Outlet Holdings'>OLLI</a>) reports comparable sales increased 2.1% in Q3.</li>     <li>Gross margin rate was down 50 bps to 41.2% of sales. A fall in merchandise margins was only partially offset by lower supply chain costs.</li>     <li>Operating income was up 100 bps to 10.2% of sales.</li>     <li>Adjusted EBITDA increased 24% to $29.M to account for 12.3% of sales vs. 11.7% a year ago.</li>     <li>The retailer expects FY18 revenue of $1.062B to $1.065B vs. $1.07B consensus and EPS of&nbsp;&nbsp;$1.21 fo $1.22 vs $1.21 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316755-ollies-bargain-outlet-beats-0_01-beats-revenue\" target=\"_blank\">Ollie's Bargain Outlet beats by $0.01, beats on revenue</a> (Dec. 6)</li><li>OLLI&nbsp;<font color='green'>+0.20%</font>&nbsp;AH to $51.10.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316767\" data-linked=\"Solid quarter posted by Ollie&#39;s Bargain Outlet\" data-tweet=\"$OLLI - Solid quarter posted by Ollie&#39;s Bargain Outlet https://seekingalpha.com/news/3316767-solid-quarter-posted-ollies-bargain-outlet?source=tweet\" data-url=\"https://seekingalpha.com/news/3316767-solid-quarter-posted-ollies-bargain-outlet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316761\" data-ts=\"1512595080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPMT\" target=\"_blank\">GPMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316761-granite-point-mortgage-convertible-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Granite Point Mortgage with convertible note offering</a></h4><ul><li>The company plans to sell up to $125M in principal amount of five-year convertible paper, with underwriter greenshoe for up to another $18.75M.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17020480-granite-point-mortgage-trust-inc-announces-proposed-private-offering-convertible-senior-notes\" target=\"_blank\">Press Release</a></li><li>Updating the business thus far in Q4, <a href='https://seekingalpha.com/symbol/GPMT' title='Granite Point Mortgage Trust'>GPMT</a> has closed commercial real estate loans totaling about $252M. The pipeline as of the start of the month was about $137M of loans, with some of this amount expected to close before year-end.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17020487-granite-point-mortgage-trust-inc-business-update\" target=\"_blank\">Press Release</a></li><li>Shares<font color='red'> down 1.4%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3316761\" data-linked=\"Granite Point Mortgage with convertible note offering\" data-tweet=\"$GPMT - Granite Point Mortgage with convertible note offering https://seekingalpha.com/news/3316761-granite-point-mortgage-convertible-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3316761-granite-point-mortgage-convertible-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316759\" data-ts=\"1512594916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316759-comparable-sales-shine-lululemon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comparable sales shine at Lululemon</a></h4><ul>     <li>Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>)&nbsp;reports comparable sales increased 8% in Q3 to blast past the consensus estimate for a 5% gain.&nbsp;On a constant dollar basis, comparable sales were up 7%.</li>     <li>Gross margin was 52.2% of sales during the quarter vs. 51.1%&nbsp; a year ago.</li>     <li>Operating margin increased 30 bps Y/Y to 17.4% of sales.</li>     <li>\"As we start the holiday season, I'm energized by our momentum and we are increasing guidance to reflect this performance,\" says Lululemon CEO Laurent Potdevin.</li>     <li>Looking ahead, Lululemon sees full-year revenue of $2.590B to $2.605B vs. $2.60B consensus and full-year EPS $2.45 to $2.48 vs. $2.40 consensus.</li>     <li>The company says the board approved a $200M share buyback plan.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316748-lululemon-athletica-beats-0_04-beats-revenue\" target=\"_blank\">Lululemon Athletica beats by $0.04, beats on revenue</a> (Dec. 6)</li>     <li>LULU <font color='green'>+6.55%</font> premarket to $72.09</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316759\" data-linked=\"Comparable sales shine at Lululemon\" data-tweet=\"$LULU - Comparable sales shine at Lululemon https://seekingalpha.com/news/3316759-comparable-sales-shine-lululemon?source=tweet\" data-url=\"https://seekingalpha.com/news/3316759-comparable-sales-shine-lululemon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316748\" data-ts=\"1512594358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316748-lululemon-athletica-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon Athletica beats by $0.04, beats on revenue</a></h4><ul><li>Lululemon Athletica (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>): Q3 EPS of $0.56 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $619M (+13.7% Y/Y) <font color='green'>beats by $9.11M</font>.</li><li>Shares <font color='green'>+3.5%</font>.</li><li><a href='https://seekingalpha.com/pr/17020468-lululemon-athletica-inc-announces-third-quarter-fiscal-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3316748\" data-linked=\"Lululemon Athletica beats by $0.04, beats on revenue\" data-tweet=\"$LULU - Lululemon Athletica beats by $0.04, beats on revenue https://seekingalpha.com/news/3316748-lululemon-athletica-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3316748-lululemon-athletica-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316746\" data-ts=\"1512594220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAC\" target=\"_blank\">SEAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316746-seachange-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SeaChange beats by $0.08, beats on revenue</a></h4><ul><li>SeaChange (NASDAQ:<a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a>): Q3 EPS of $0.09 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $23.4M (+17.2% Y/Y) <font color='green'>beats by $3.89M</font>.</li><li>Shares <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/pr/17020441-seachange-international-reports-third-quarter-fiscal-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3316746\" data-linked=\"SeaChange beats by $0.08, beats on revenue\" data-tweet=\"$SEAC - SeaChange beats by $0.08, beats on revenue https://seekingalpha.com/news/3316746-seachange-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3316746-seachange-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316745\" data-ts=\"1512594177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316745-citi-joins-jpmorgan-and-bofa-in-seeing-lame-q4-trading-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi joins JPMorgan and BofA in seeing lame Q4 trading revenue</a></h4><ul><li>Speaking at an investor conference, Citigroup (NYSE:<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a>) CFO John Gerspach says to expect a \"high teens\" year-over-year decline in trading revenue in Q4. That's a bit worse than the 15% floated by JPMorgan and Bank of America yesterday.</li><li>Gerspach also sees the bank booking a $20B charge (presumably against its DTA) if the Senate tax bill becomes law.</li><li>Citi added to the day's losses as Gerspach spoke, closing&nbsp;<font color='red'>down 1.45%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316745\" data-linked=\"Citi joins JPMorgan and BofA in seeing lame Q4 trading revenue\" data-tweet=\"$C - Citi joins JPMorgan and BofA in seeing lame Q4 trading revenue https://seekingalpha.com/news/3316745-citi-joins-jpmorgan-and-bofa-in-seeing-lame-q4-trading-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3316745-citi-joins-jpmorgan-and-bofa-in-seeing-lame-q4-trading-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316742\" data-ts=\"1512593921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMST\" target=\"_blank\">TMST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316742-timkensteelminus-14-after-keybanc-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TimkenSteel -14% after KeyBanc downgrade</a></h4><ul>     <li>TimkenSteel (<a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-14.1%</font>) tumbles after KeyBanc <a href=\"https://thefly.com/thestreet/realmoney/index.php/TMSTid2650931/TMST-TimkenSteel-downgraded-to-Underweight-from-Sector-Weight-at-KeyBanc\" target=\"_blank\">downgrades</a> shares to Underweight from Sector Weight with a $12 price target, as the firm says its conversations with supply chain contacts indicate 2018 contract pricing upside likely will fall meaningfully short of YTD spot pricing upside near $110/ton.</li><li>KeyBanc says it now has a \"materially more conservative\" view on 2018 annual SBQ contract pricing.</li><li>TMST's losses are all the more glaring in light of <a href=\"https://seekingalpha.com/news/3316678-u-s-steel-ak-steel-surge-tariff-ruling-axioms-johnson-pooh-poohs-news\" target=\"_blank\">gains across the rest of the steel sector</a> following the U.S. government's move to slap steep import duties on steel from Vietnam that originated in China.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316742\" data-linked=\"TimkenSteel -14% after KeyBanc downgrade\" data-tweet=\"$TMST - TimkenSteel -14% after KeyBanc downgrade https://seekingalpha.com/news/3316742-timkensteelminus-14-after-keybanc-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3316742-timkensteelminus-14-after-keybanc-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316740\" data-ts=\"1512593353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316740-qualcomm-reveals-snapdragon-845-detail\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm reveals Snapdragon 845 detail</a></h4><ul><li>        Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <a href=\"https://www.reuters.com/article/qualcomm-chips/qualcomm-adds-security-battery-life-features-to-phone-chips-idUSL1N1O52HR?feedType=RSS&amp;feedName=companyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FcompanyNews+%28News+%2F+US+%2F+Company+News%29\" target=\"_blank\">releases details</a> about its new Snapdragon 845 mobile phone chip, which will power high-end Android phones.</li><li>               The Snapdragon 845 is built to increase security and battery life and optimized for AI tasks.&nbsp;</li><li>               The 845 marks the first time a Snapdragon chip has a separate Secure Processing Unit to store information including fingerprints and iris scans.&nbsp;</li><li>               A strong chip debut could help Qualcomm&rsquo;s position amid an ongoing court battle with Apple, delayed NXP Semiconductors acquisition, and takeover offer from Broadcom that could become hostile. &nbsp;&nbsp;</li><li>Qualcomm shares are&nbsp;<font color='green'>up 0.69%</font>.&nbsp; &nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316498-amd-confirms-working-qualcomm-always-connected-pcs\" target=\"_blank\">AMD confirms working with Qualcomm on Always Connected PCs</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316740\" data-linked=\"Qualcomm reveals Snapdragon 845 detail\" data-tweet=\"$QCOM - Qualcomm reveals Snapdragon 845 detail https://seekingalpha.com/news/3316740-qualcomm-reveals-snapdragon-845-detail?source=tweet\" data-url=\"https://seekingalpha.com/news/3316740-qualcomm-reveals-snapdragon-845-detail\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316736\" data-ts=\"1512593223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316736-merck-weak-ahead-of-roche-data-release-from-late-stage-study-of-tecentriq-in-lung-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3%</a></h4><ul><li>Merck (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='red'>-2.7%</font>) slumps on over 50% higher volume ahead of an expected announcement tomorrow by Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='green'>+1.4%</font>) of results from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02366143?term=impower+150&amp;rank=1\" target=\"_blank\">IMPOWER 150</a>, assessing TECENTRIQ (atezolizumab), in combination with carboplatin and paclitaxel (C+P), with or without Avastin (bevacizumab), compared to C+P+Avastin in chemo-naive patients with metastatic non-squamous non-small cell lung cancer &#40;NSCLC&#41;.</li><li>The co-primary endpoints are progression-free survival &#40;PGS&#41; and overall survival &#40;OS&#41; up to ~32 months.</li><li>The data will be presented at the ESMO Immuno Oncology Congress in Geneva.</li><li>Merck is evaluating KEYTRUDA (pembrolizumab), in combination with pemetrexed/platinum chemo, in the same population of lung cancer patients in the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02578680?term=keynote-189&amp;rank=1\" target=\"_blank\">Keynote-189</a> study with the same PFS and OS endpoints. The expected outcome has been under a bit of a cloud since the company withdrew its European marketing application in October.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3305392-merck-withdraws-european-marketing-application-keytruda-first-line-nsclc\" target=\"_blank\">Merck withdraws European marketing application for Keytruda in first-line NSCLC</a> (Oct. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316736\" data-linked=\"Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3%\" data-tweet=\"$MRK $MRK $RHHBY - Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3% https://seekingalpha.com/news/3316736-merck-weak-ahead-of-roche-data-release-from-late-stage-study-of-tecentriq-in-lung-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3316736-merck-weak-ahead-of-roche-data-release-from-late-stage-study-of-tecentriq-in-lung-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316726\" data-ts=\"1512590137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNX\" target=\"_blank\">MLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316726-mellanox-techplus-2_1-on-bank-talks-rumor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mellanox Tech +2.1% on bank talks rumor</a></h4><ul><li>        Mellanox Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNX' title='Mellanox Technologies, Ltd.'>MLNX</a>) shares are&nbsp;<font color='green'>up 2.1%&nbsp;</font>on <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=2&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiLyJjok_bXAhUq2IMKHYtgA0MQFggvMAE&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FRumors%2FMellanox%2BTechnologies%2B%28MLNX%29%2BSaid%2Bto%2BInterview%2BBanks%2BAmid%2BStarboard%2BPush%2B-%2BBloomberg%2C%2BCiting%2BDealReporter%2F13575234.html&amp;usg=AOvVaw2Fv2c4VSvFezPUAaZkYwqm\" target=\"_blank\">rumors</a> that the company is interviewing banks due to pressure from Starboard.</li><li>               Source: Bloomberg, citing DealReporter.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3313689-starboard-value-discloses-10_7-percent-stake-mellanox-wants-explore-sale\" target=\"_blank\">Starboard Value discloses 10.7% stake in Mellanox, wants to explore sale</a> (Nov. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316726\" data-linked=\"Mellanox Tech +2.1% on bank talks rumor\" data-tweet=\"$MLNX - Mellanox Tech +2.1% on bank talks rumor https://seekingalpha.com/news/3316726-mellanox-techplus-2_1-on-bank-talks-rumor?source=tweet\" data-url=\"https://seekingalpha.com/news/3316726-mellanox-techplus-2_1-on-bank-talks-rumor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316727\" data-ts=\"1512590106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316727-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><strong>Gainers</strong>: <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AYX' title='Alteryx'>AYX</a> <font color='green'>+9%</font>.</li>     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/TRT' title='Trio-Tech International'>TRT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd.'>SOL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ATTU' title='Attunity Ltd'>ATTU</a> <font color='red'>-11%</font>.</li>     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3316727\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$DPW $MOXC $ANY - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3316727-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3316727-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316725\" data-ts=\"1512589452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREE\" target=\"_blank\">CREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316725-cree-confirms-exit-of-two-execs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cree confirms exit of two execs</a></h4><ul><li>        Cree (NASDAQ:<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a>) <a href=\"https://www.bizjournals.com/triangle/news/2017/12/05/top-lighting-execs-leave-cree.html\" target=\"_blank\">confirms</a> to the Triangle Business Journal reports that two top execs have left the company.</li><li>               The departures were Daniel Castillo, president of the lighting division, and Keith Eagles, SVP of sales at the commercial lighting business.&nbsp;</li><li>               Both came to the company from Eaton last year and left shortly after Gregg Lowe took the CEO reins and promised a new strategic plan for the company.&nbsp;</li><li>                  Cree shares are&nbsp;<font color='red'>down 1.3%</font>.<br />    &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3316725\" data-linked=\"Cree confirms exit of two execs\" data-tweet=\"$CREE - Cree confirms exit of two execs https://seekingalpha.com/news/3316725-cree-confirms-exit-of-two-execs?source=tweet\" data-url=\"https://seekingalpha.com/news/3316725-cree-confirms-exit-of-two-execs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316715\" data-ts=\"1512586857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316715-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ASM' title='Avino Silver & Gold Mines Ltd'>ASM</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/TROX' title='Tronox Inc.'>TROX</a> <font color='red'>-25%</font>. BBG <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316715\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$WLB $ASM $X - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3316715-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3316715-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316714\" data-ts=\"1512586265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316714-allergans-saunders-buys-4600-shares-on-open-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan&#39;s Saunders buys 4600 shares on open market</a></h4><ul><li>Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='green'>+1.6%</font>) CEO Brent Saunders has <a href=\"https://seekingalpha.com/filing/3789868\" target=\"_blank\">purchased</a> 4600 ordinary shares at ~$164.74 per share on the open market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316714\" data-linked=\"Allergan&#39;s Saunders buys 4600 shares on open market\" data-tweet=\"$AGN - Allergan&#39;s Saunders buys 4600 shares on open market https://seekingalpha.com/news/3316714-allergans-saunders-buys-4600-shares-on-open-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3316714-allergans-saunders-buys-4600-shares-on-open-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316712\" data-ts=\"1512586135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316712-recode-oracle-waging-war-on-google\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recode: Oracle waging war on Google</a></h4><ul><li>        <a href=\"https://www.recode.net/2017/12/6/16721364/oracle-google-political-war-location-track-android-safra-catz-java-lawsuit\" target=\"_blank\">Recode</a> reports that last month&rsquo;s revelation that Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>) was tracking Android users without permission came from rival Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>). &nbsp;</li><li>           Recode&rsquo;s sources say Oracle has mounted a campaign against Google for the past year as the companies fight in federal court. </li><li> Other actions Oracle has taken against Google: $8.8M in lobbying, seeking EU penalties, and anti-Google billboards in Tennessee. </li><li>           The legal fight goes back to 2010 when Oracle accused Google of copying Java to create Android. The next oral arguments in the current appeal begin tomorrow.  </li><li> In other Google legal news, a California court <a href=\"https://www.reuters.com/article/us-google-lawsuit/google-beats-class-action-sex-bias-claims-for-now-idUSKBN1E02I5\" target=\"_blank\">dismissed</a> class action claims that accused the company of sex-based discrimination. </li><li> Judge Mary Wiss said the lawsuit wasn&rsquo;t appropriate because it included all female Google employees. The plaintiffs have 30 days to file a complaint on behalf of only the women who experienced pay discrimination.&nbsp; </li><li> Oracle shares are&nbsp;<font color='green'>up 0.9%</font>. </li><li> Google shares are&nbsp;<font color='green'>up 1.4%</font>.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3316712\" data-linked=\"Recode: Oracle waging war on Google\" data-tweet=\"$GOOG $GOOG $GOOGL - Recode: Oracle waging war on Google https://seekingalpha.com/news/3316712-recode-oracle-waging-war-on-google?source=tweet\" data-url=\"https://seekingalpha.com/news/3316712-recode-oracle-waging-war-on-google\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316711\" data-ts=\"1512586061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316711-immunomedics-immuminus-132-shows-31-response-rate-in-tnbc-shares-ahead-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics&#39; IMMU-132 shows 31% response rate in TNBC; shares ahead 19%</a></h4><ul><li>Immunomedics (<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+19%</font>) is up triple normal although it has retraced 7% from its intraday high of $11.85.</li><li>The company just <a href=\"https://seekingalpha.com/pr/17020254-immunomedics-announces-updated-results-sacituzumab-govitecan-immuminus-132-patients-relapsed\" target=\"_blank\">announced </a>independently reviewed data from a Phase 2 clinical trial assessing IMMU-132 (sacituzumab govitecan) in patients with metastatic triple-negative breast cancer &#40;TNBC&#41;.</li><li>The overall response rate was 31% (n=34/110) including six complete responders and 28 partial responders. Median duration of response was 9.1 months. 34% (n=37/110) of the patients received at least three prior lines of therapy before IMMU-132.</li><li>The company will host an investor event today at 10:00 pm ET in San Antonio. Audio and slides will be webcast live via the Investor section on its website.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316689-immunomedics-rallies-17-percent-ahead-data-release-lead-candidate-immuminus-132\" target=\"_blank\">Immunomedics rallies 17% ahead of data release on lead candidate IMMU-132</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316711\" data-linked=\"Immunomedics&#39; IMMU-132 shows 31% response rate in TNBC; shares ahead 19%\" data-tweet=\"$IMMU - Immunomedics&#39; IMMU-132 shows 31% response rate in TNBC; shares ahead 19% https://seekingalpha.com/news/3316711-immunomedics-immuminus-132-shows-31-response-rate-in-tnbc-shares-ahead-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3316711-immunomedics-immuminus-132-shows-31-response-rate-in-tnbc-shares-ahead-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316707\" data-ts=\"1512584196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYI\" target=\"_blank\">AYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316707-acuity-brandsminus-3_8-after-pacific-square-research-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acuity Brands -3.8% after Pacific Square Research mention</a></h4><ul><li>        Acuity Brands (NYSE:<a href='https://seekingalpha.com/symbol/AYI' title='Acuity Brands, Inc. &#40;Holding Company&#41;'>AYI</a>) shares are down 3.4% after a <a href=\"http://www.streetinsider.com/Short+Sales/Acuity+Brands+%28AYI%29+Mentioned+Cautiously+by+Short-Focused+Research+Firm/13574523.html\" target=\"_blank\">cautious mention</a> by Pacific Square Research.</li><li>               The firm issued a Red Flag warning on concerns about rapid growth deceleration, intense competition in the LED market, and price declines.&nbsp;</li><li>               The firm also notes softness across industries, cash flow declines, and deteriorating margins.&nbsp;</li><li>               Acuity Brands shares are&nbsp;<font color='red'>down 3.8%.</font>&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3316707\" data-linked=\"Acuity Brands -3.8% after Pacific Square Research mention\" data-tweet=\"$AYI - Acuity Brands -3.8% after Pacific Square Research mention https://seekingalpha.com/news/3316707-acuity-brandsminus-3_8-after-pacific-square-research-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3316707-acuity-brandsminus-3_8-after-pacific-square-research-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316706\" data-ts=\"1512583887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316706-successful-test-of-lightning-network-announced\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Successful test of Lightning Network announced</a></h4><ul><li>Causing some excitement in the cryptocurrency world in the past few minutes is <a href=\"https://medium.com/@lightning_network/lightning-protocol-1-0-compatibility-achieved-f9d22b7b19c4\" target=\"_blank\">the release of version 1.0</a> of the Lightning protocol specification, along with a successful cross-implementation test on Bitcoin mainnet.</li><li>In the first test, a coffee was purchased from <em>Starblocks</em>, and in the second an article from yalls.org - both in milliseconds.</li><li>Bitcoin remains sharply higher,&nbsp;<font color='green'>up 9%&nbsp;</font>to $12,734. Ether is&nbsp;<font color='red'>lower by 3.9</font><font color='red'>%</font>, and Litecoin in flat.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3316706\" data-linked=\"Successful test of Lightning Network announced\" data-tweet=\"$GBTC $GBTC $COIN - Successful test of Lightning Network announced https://seekingalpha.com/news/3316706-successful-test-of-lightning-network-announced?source=tweet\" data-url=\"https://seekingalpha.com/news/3316706-successful-test-of-lightning-network-announced\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316697\" data-ts=\"1512583291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VKTX\" target=\"_blank\">VKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316697-madrigals-mid-stage-success-nash-candidate-mglminus-3196-stokes-viking-therapeutics-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Madrigal&#39;s mid-stage success with NASH candidate MGL-3196 stokes Viking Therapeutics, up 2%</a></h4><ul><li>Nano cap Viking Therapeutics (<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+2.2%</font>) remains in positive territory on a 10x surge in volume despite retracing 20% from its intraday high of $3.51.</li><li>The action appears to be related to Madrigal Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+76.1%</font>), up big after it announced positive Phase 2 results on NASH candidate MGL-3196, a selective agonist of a protein called <a href=\"https://en.wikipedia.org/wiki/Thyroid_hormone_receptor_beta\" target=\"_blank\">thyroid hormone receptor-beta</a>.</li><li>Viking's NASH candidate, <a href=\"http://www.vikingtherapeutics.com/pipeline/vk0214/\" target=\"_blank\">VK2809</a>, has the same mechanism of action. Topline results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02927184?term=vk2809&amp;rank=1\" target=\"_blank\">Phase 2 study </a>should be available soon. According to ClinicalTrials.gov, the estimated completion date is this month.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316620-madrigal-pharmas-lead-candidate-successful-mid-stage-nash-study-shares-ahead-45-percent\" target=\"_blank\">Madrigal Pharma's lead candidate successful in mid-stage NASH study; shares ahead 45% premarket</a> (Dec. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3303299-viking-therapeutics-vk2809-shows-positive-effect-nash-model-shares-ahead-9-percent-premarket\" target=\"_blank\">Viking Therapeutics' VK2809 shows positive effect in NASH model; shares ahead 9% premarket</a> (Oct. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316697\" data-linked=\"Madrigal&#39;s mid-stage success with NASH candidate MGL-3196 stokes Viking Therapeutics, up 2%\" data-tweet=\"$VKTX $VKTX $MDGL - Madrigal&#39;s mid-stage success with NASH candidate MGL-3196 stokes Viking Therapeutics, up 2% https://seekingalpha.com/news/3316697-madrigals-mid-stage-success-nash-candidate-mglminus-3196-stokes-viking-therapeutics-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3316697-madrigals-mid-stage-success-nash-candidate-mglminus-3196-stokes-viking-therapeutics-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316701\" data-ts=\"1512583260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRA\" target=\"_blank\">VRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316701-investor-show-confidence-in-vera-bradley-turnaround\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investor show confidence in Vera Bradley turnaround</a></h4><ul>     <li>Vera Bradley (NASDAQ:<a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a>) is&nbsp;<font color='green'>up 29%&nbsp;</font>to trade at its highest level in a month.</li>     <li>Jefferies says investors are backing the retailer's shift away from a clearance model to focus on restoring the full price business.</li>     <li>The firm is also giving recently appointed Creative Officer Beatrice Mac Cabe credit for sparking a turnaround at Vera.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3316617-vera-bradley-higher-earnings\" target=\"_blank\">Vera Bradley higher after earnings</a> (Dec. 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316701\" data-linked=\"Investor show confidence in Vera Bradley turnaround\" data-tweet=\"$VRA - Investor show confidence in Vera Bradley turnaround https://seekingalpha.com/news/3316701-investor-show-confidence-in-vera-bradley-turnaround?source=tweet\" data-url=\"https://seekingalpha.com/news/3316701-investor-show-confidence-in-vera-bradley-turnaround\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316699\" data-ts=\"1512583202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316699-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NAVG' title='The Navigators Group, Inc.'>NAVG</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/XIN' title='Xinyuan Real Estate Co., Ltd.'>XIN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316699\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$YIN $FPAY $OPHC - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3316699-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3316699-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316696\" data-ts=\"1512582533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGEAF\" target=\"_blank\">CGEAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316696-rogers-considers-sale-of-blue-jays-cogeco-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rogers considers sale of Blue Jays, Cogeco stake</a></h4><ul>   <li>Rogers Communications (<a href=\"http://seekingalpha.com/symbol/RCI\" target=\"_blank\">RCI</a> <font color='red'>-0.1%</font>) is examining asset sales, CFO Tony Staffieri says, which may reach to the <a href=\"https://uk.reuters.com/article/us-rci-divestiture/canadas-rogers-considers-selling-blue-jays-cogeco-stake-idUKKBN1E00D0\" target=\"_blank\">Toronto Blue Jays baseball club</a> and the company's stake in Cogeco (<a href='https://seekingalpha.com/symbol/CGEAF' title='Cogeco Communications Inc'>OTCPK:CGEAF</a>).</li>    <li>Speaking at a UBS conference, Staffieri says the company doesn't need to own the Blue Jays to hold on to programming rights.</li>    <li>Selling assets will free up capital for other investments, he says.</li>    <li>Cogeco shares are <font color='red'>down 1.8%</font> in Toronto.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316696\" data-linked=\"Rogers considers sale of Blue Jays, Cogeco stake\" data-tweet=\"$CGEAF $CGEAF $RCI - Rogers considers sale of Blue Jays, Cogeco stake https://seekingalpha.com/news/3316696-rogers-considers-sale-of-blue-jays-cogeco-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3316696-rogers-considers-sale-of-blue-jays-cogeco-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316695\" data-ts=\"1512582338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316695-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+73%</font>. CLNT <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corp.'>CLIR</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ASTC' title='Astrotech Corporation'>ASTC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/WSCI' title='WSI Industries Inc.'>WSCI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-34%</font>. <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/TROX' title='Tronox Inc.'>TROX</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/OSIS' title='OSI Systems, Inc.'>OSIS</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/PXS' title='Pyxis Tankers Inc.'>PXS</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CHKE' title='Cherokee Inc.'>CHKE</a> <font color='red'>-19%</font>. BBG <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/LQDT' title='Liquidity Services, Inc.'>LQDT</a> <font color='red'>-17%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316695\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$MDGL $SEII $AVAV - Midday Gainers / Losers https://seekingalpha.com/news/3316695-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3316695-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316665\" data-ts=\"1512581839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGL\" target=\"_blank\">MDGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316665-nash-drug-developers-in-red-after-madrigals-mid-stage-success-mglminus-3196\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NASH drug developers in the red after Madrigal&#39;s mid-stage success with MGL-3196</a></h4><ul><li>Investors are swarming over Madrigal Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+79.8%</font>) after it reported positive results from a Phase 2 clinical trial assessing MGL-3196 in NASH patients. Certain would-be NASH players have been brushed aside in early trading.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a> <font color='green'>+0.9%</font>)(<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a>)(<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-2.2%</font>)(<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='green'>+1.6%</font>)(<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='red'>-8.7%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='red'>-1.2%</font>)(<a href='https://seekingalpha.com/symbol/GNFTF' title='Genfit'>OTCPK:GNFTF</a> <font color='red'>-5%</font>)(<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+2.6%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316620-madrigal-pharmas-lead-candidate-successful-mid-stage-nash-study-shares-ahead-45-percent\" target=\"_blank\">Madrigal Pharma's lead candidate successful in mid-stage NASH study; shares ahead 45% premarket</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316665\" data-linked=\"NASH drug developers in the red after Madrigal&#39;s mid-stage success with MGL-3196\" data-tweet=\"$MDGL $MDGL $MNOV - NASH drug developers in the red after Madrigal&#39;s mid-stage success with MGL-3196 https://seekingalpha.com/news/3316665-nash-drug-developers-in-red-after-madrigals-mid-stage-success-mglminus-3196?source=tweet\" data-url=\"https://seekingalpha.com/news/3316665-nash-drug-developers-in-red-after-madrigals-mid-stage-success-mglminus-3196\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316692\" data-ts=\"1512581476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEAR\" target=\"_blank\">TEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316692-tearlab-equity-offering-pressures-shares-down-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TearLab equity offering pressures shares, down 17%</a></h4><ul><li>Thinly traded nano cap TearLab (<a href='https://seekingalpha.com/symbol/TEAR' title='TearLab Corporation'>TEAR</a> <font color='red'>-17.2%</font>) slumps on modestly higher volume in response to is <a href=\"https://seekingalpha.com/pr/17019597-tearlab-prices-3_0-million-registered-direct-offering\" target=\"_blank\">direct offering</a> of ~6.8M units at $0.44 per unit.</li><li>Each unit consists of one share of common stock, one Series A warrant and one Series B warrant.</li><li>Each five-year Series A warrant is exercisable at $0.44 per common share. Each six-month Series B warrant is also exercisable at $0.44 per common share.</li><li>Closing date is December 8.</li><li>Yesterday's close was $0.6303.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316692\" data-linked=\"TearLab equity offering pressures shares, down 17%\" data-tweet=\"$TEAR - TearLab equity offering pressures shares, down 17% https://seekingalpha.com/news/3316692-tearlab-equity-offering-pressures-shares-down-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3316692-tearlab-equity-offering-pressures-shares-down-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316690\" data-ts=\"1512581030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316690-infosys-wants-settlement-on-ex-cfo-payout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infosys wants settlement on ex-CFO payout</a></h4><ul><li>        Infosys (NASDAQ:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>) <a href=\"https://in.reuters.com/article/infosys-regulator/infosys-seeks-settlement-with-regulator-on-ex-cfos-severance-pay-idINKBN1E028N?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FINbusinessNews+%28News+%2F+IN+%2F+Business+News%29\" target=\"_blank\">wants to settle</a> with India&rsquo;s market regulator regarding a severance package for its former CFO Rajiv Bansal.</li><li>               Infosys applied to the Securities and Exchange Board of India to resolve allegations surrounding the package, which included not seeking committee approval and failing to disclose the payout properly.&nbsp;</li><li>               Objections to Bansal&rsquo;s payout led to infighting and the resignation of then CEO Vishal Sikka and chairman R. Seshasayee. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3315895-infosys-taps-another-outsider-ceo\" target=\"_blank\">Infosys taps another outsider as CEO</a> (Dec. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316690\" data-linked=\"Infosys wants settlement on ex-CFO payout\" data-tweet=\"$INFY - Infosys wants settlement on ex-CFO payout https://seekingalpha.com/news/3316690-infosys-wants-settlement-on-ex-cfo-payout?source=tweet\" data-url=\"https://seekingalpha.com/news/3316690-infosys-wants-settlement-on-ex-cfo-payout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316689\" data-ts=\"1512580943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316689-immunomedics-rallies-17-ahead-of-data-release-on-lead-candidate-immuminus-132\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics rallies 17% ahead of data release on lead candidate IMMU-132</a></h4><ul><li>Immunomedics (<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+16.9%</font>) jumps on modestly higher volume ahead its expected data release from a Phase 2 clinical trial assessing lead candidate IMMU-132 (sacituzumab govitecan) in women with triple negative breast cancer.</li><li>The objective response rate of 34% was announced previously but investors are waiting for the results from an independent blinded review of the data. The announcement will be made at the San Antonio Breast Cancer Symposium.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3311585-wells-defends-immunomedics-19-percent-selloff-buying-opportunity\" target=\"_blank\">Wells defends Immunomedics, 19% selloff a \"buying opportunity\"</a> (Nov. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316689\" data-linked=\"Immunomedics rallies 17% ahead of data release on lead candidate IMMU-132\" data-tweet=\"$IMMU - Immunomedics rallies 17% ahead of data release on lead candidate IMMU-132 https://seekingalpha.com/news/3316689-immunomedics-rallies-17-ahead-of-data-release-on-lead-candidate-immuminus-132?source=tweet\" data-url=\"https://seekingalpha.com/news/3316689-immunomedics-rallies-17-ahead-of-data-release-on-lead-candidate-immuminus-132\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316685\" data-ts=\"1512579757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316685-himaxminus-10_2-after-citron-research-tweet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax -10.2% after Citron Research tweet</a></h4><ul><li>        Himax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) shares are down 9.9% after a Citron Research <a href=\"https://twitter.com/CitronResearch/status/938440330847838208\" target=\"_blank\">tweet</a>.</li><li>               Citron again accuses Himax of fraud and that it &ldquo;looks like market starting to realize&rdquo; the bogus story behind the company.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3310443-himax-technologies-q3-beats-mixed-guidance\" target=\"_blank\">Himax Technologies up after Q3 beats, mixed guidance</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316685\" data-linked=\"Himax -10.2% after Citron Research tweet\" data-tweet=\"$HIMX - Himax -10.2% after Citron Research tweet https://seekingalpha.com/news/3316685-himaxminus-10_2-after-citron-research-tweet?source=tweet\" data-url=\"https://seekingalpha.com/news/3316685-himaxminus-10_2-after-citron-research-tweet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>116&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316683\" data-ts=\"1512579648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316683-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries Inc.'>OXM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/FBR' title='Fibria Celulose S.A.'>FBR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316683\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$VRA $OXM $FBR - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3316683-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3316683-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316681\" data-ts=\"1512579315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316681-apple-suppliers-drop-after-largan-warns-of-lower-dec-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple suppliers drop after Largan warns of lower Dec. revenue</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) supplier Largan Precision (<a href='https://seekingalpha.com/symbol/LGANF' title='Largan Precision Co., Ltd.'>OTC:LGANF</a>) warns of <a href=\"https://asia.nikkei.com/Business/AC/Largan-Precision-shares-plunge-on-report-of-sales-drop\" target=\"_blank\">lower December revenue</a> compared to the previous month.</li><li>               Largan had $187.2M in November sales, which was flat on October but up 8% on the year.&nbsp;</li><li>                  The revenue drop comes in a period that&rsquo;s traditionally strong for iPhone shipments. Largan supplies lenses and Face ID modules for the devices.    </li><li>               Taiwan&rsquo;s Economic Daily News reports that Largan&rsquo;s weak December comes from a drop in orders but didn&rsquo;t specify from which customers.&nbsp;</li><li>               Yuanta Investment Consulting analyst Jeff Pu thinks Apple has cut back iPhone X orders from 69M to 63M for the November to March period after previously cutting iPhone 8 and 8 Plus for 1Q18 to 16M units, half of the current quarter. &nbsp;&nbsp;</li><li>               Apple suppliers moving on the news: Skyworks Solutions (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='red'>-0.8%</font>), Cirrus Logic (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='red'>-1.6%</font>), Broadcom (<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='red'>-1.2%</font>), and Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-3.8%</font>).&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3316681\" data-linked=\"Apple suppliers drop after Largan warns of lower Dec. revenue\" data-tweet=\"$AAPL $AAPL $LGANF - Apple suppliers drop after Largan warns of lower Dec. revenue https://seekingalpha.com/news/3316681-apple-suppliers-drop-after-largan-warns-of-lower-dec-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3316681-apple-suppliers-drop-after-largan-warns-of-lower-dec-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316678\" data-ts=\"1512578358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316678-u-s-steel-ak-steel-surge-on-tariff-ruling-axioms-johnson-pooh-poohs-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel, AK Steel surge on tariff ruling; Axiom&#39;s Johnson pooh-poohs news</a></h4><ul>     <li>Steel names including U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+6.4%</font>) and AK&nbsp;Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+5.5%</font>) enjoy hefty gains following the Commerce Department's move to <a href=\"https://seekingalpha.com/news/3316522-u-s-hits-vietnam-steel-duties\" target=\"_blank\">impose import duties</a> on steel from Vietnam that originated in China.</li>     <li>While the market is rewarding the shares today, Axiom Capital's Gordon Johnson maintains the DoC's decision is \"<a href=\"https://www.barrons.com/articles/tariffic-or-terrible-steel-import-tariffs-and-the-u-s-1512576247\" target=\"_blank\">virtually irrelevant in terms of supply/demand</a>.\"</li>     <li>Johnson says imports of cold rolled coil and hot-dip galvanizing steel have \"virtually collapsed\" since November of last year.</li>     <li>Vietnam suppliers say their product does not include Chinese components, and U.S. importers have continued to buy their steel, meaning that Johnson expects about half of the current imported Vietnamese steel gets banned incrementally.</li>     <li>Also:&nbsp;<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+1.2%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+1.3%</font>, <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+2.4%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+1.9%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+1.3%</font>, <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='green'>+0.4%</font>, <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='green'>+0.8%</font>, <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a> <font color='green'>+0.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316678\" data-linked=\"U.S. Steel, AK Steel surge on tariff ruling; Axiom&#39;s Johnson pooh-poohs news\" data-tweet=\"$X $X $AKS - U.S. Steel, AK Steel surge on tariff ruling; Axiom&#39;s Johnson pooh-poohs news https://seekingalpha.com/news/3316678-u-s-steel-ak-steel-surge-on-tariff-ruling-axioms-johnson-pooh-poohs-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3316678-u-s-steel-ak-steel-surge-on-tariff-ruling-axioms-johnson-pooh-poohs-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316676\" data-ts=\"1512577786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JW.A\" target=\"_blank\">JW.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316676-wiley-2_5-year-highs-after-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wiley at 2.5-year highs after earnings beat</a></h4><ul>   <li>John Wiley &amp; Sons (NYSE:<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a>) is <font color='green'>up 2%</font> and setting new 2.5-year highs today after <a href=\"https://seekingalpha.com/news/3316588-john-wiley-and-sons-beats-0_21-beats-revenue\" target=\"_blank\">fiscal Q2 earnings report</a> where it beat expectations on top and bottom lines.</li>    <li>EPS rose 32% (22% in constant currency), as lower interest expense combined with higher operating income.</li>    <li>Revenue rose 6% and was up 3% in constant currency, mainly driven by growth in research journals, STM and Professional Publishing, and Education Services/Online Program Management.</li>    <li>Revenue by segment: Research, $228.9M (up 11%); Publishing, $165M (up 1%); Solutions, $57.9M (up 3%).</li>    <li>It's reaffirmed fiscal 2018 guidance for revenue about even with 2017's $1.719B and adjusted EPS declining in the low single digits from 2017's $3.01. It also sees cash from operations rising to $350M or more, and capex slightly lower than this year's $148.3M.</li>    <li><a href=\"https://seekingalpha.com/pr/17019699-wiley-reports-second-quarter-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3316676\" data-linked=\"Wiley at 2.5-year highs after earnings beat\" data-tweet=\"$JW.A $JW.B - Wiley at 2.5-year highs after earnings beat https://seekingalpha.com/news/3316676-wiley-2_5-year-highs-after-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3316676-wiley-2_5-year-highs-after-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316674\" data-ts=\"1512577687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQNS\" target=\"_blank\">SQNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316674-sequans-files-for-mixed-shelf\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sequans files for mixed shelf</a></h4><ul><li>        Sequans Communications (NYSE:<a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a>) files for a mixed shelf of up to $100M.</li><li>               Certain selling security holders can offer nd sell up to 10M American Depository Shares.&nbsp;</li><li>               Sequans shares are&nbsp;<font color='red'>down 2.76%</font>. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3305999-sequans-communications-reports-q3-results-line-guidance\" target=\"_blank\">Sequans Communications reports Q3 results and in-line guidance</a> (Oct. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316674\" data-linked=\"Sequans files for mixed shelf\" data-tweet=\"$SQNS - Sequans files for mixed shelf https://seekingalpha.com/news/3316674-sequans-files-for-mixed-shelf?source=tweet\" data-url=\"https://seekingalpha.com/news/3316674-sequans-files-for-mixed-shelf\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316672\" data-ts=\"1512577162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIX\" target=\"_blank\">EIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316672-edison-down-another-1_5-california-wildfires-spread\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edison down another 1.5% as California wildfires spread</a></h4><ul>     <li>Shares of Edison International (<a href='https://seekingalpha.com/symbol/EIX' title='Edison International'>EIX</a> <font color='red'>-1.5%</font>) keep falling as the southern California fires keep spreading, as tens of thousands residents in the northern Los Angeles foothills are <a href=\"https://www.cnbc.com/2017/12/06/wildfire-forces-thousands-to-flee-homes-north-of-los-angeles.html\" target=\"_blank\">forced to evacuate</a> amid power outages throughout the area.</li>     <li>Five wildfires are raging in the Los Angeles area, near Bel-Air, Ventura, Sylmar, Santa Clarita and San Bernadino.</li>     <li>A fire burning near the Getty Center <a href=\"http://www.latimes.com/local/lanow/la-me-ln-brentwood-fire-20171206-story.html\" target=\"_blank\">closed large portions of the 405 freeway</a> just as rush hour got under way this morning; the Los Angeles Fire Department says more than 200 firefighters are fighting the blaze near the 405.</li><li>Shares are <a href=\"https://www.streetinsider.com/Analyst+Comments/Mizuho+Securities+Downgrades+Edison+International+%28EIX%29+to+Neutral%2C+Too+Much+Smoke+To+See+Clearly/13572979.html\" target=\"_blank\">downgraded</a> to Neutral from Buy at Mizuho, while Deutsche Bank <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Edison+International+%28EIX%29+PT+Lowered+to+%2478+at+Deutsche+Bank+Citing+Removed+Premium+for+California%2C+Fires+bring+another+overhang/13573838.html\" target=\"_blank\">cuts its stock price target</a> for EIX to $78 and SunTrust <a href=\"https://www.streetinsider.com/Analyst+PT+Change/UPDATE%3A+Edison+International+%28EIX%29+PT+Lowered+to+%2485+at+SunTrust+Robinson+Humphrey%2C+Remains+Positive+Noting+Belief+Co.+Has+competitively+advantaged+position+in+the+B2B+Credit+Info+market/13573951.html\" target=\"_blank\">trims its target price</a> to $85.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316672\" data-linked=\"Edison down another 1.5% as California wildfires spread\" data-tweet=\"$EIX - Edison down another 1.5% as California wildfires spread https://seekingalpha.com/news/3316672-edison-down-another-1_5-california-wildfires-spread?source=tweet\" data-url=\"https://seekingalpha.com/news/3316672-edison-down-another-1_5-california-wildfires-spread\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316671\" data-ts=\"1512576414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316671-biocepts-equity-offering-pressures-shares-down-36\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept&#39;s equity offering pressures shares, down 36%</a></h4><ul><li>Biocept (<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-35.7%</font>) slumps on a 7x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17019715-biocept-announces-pricing-public-offering-4925-936-shares-common-stock\" target=\"_blank\">public offering</a> of ~4.9M shares of common stock at $0.68 per share. Net proceeds should be ~$3M. Closing date is tomorrow, December 7.</li><li>Yesterday's close was $1.15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316671\" data-linked=\"Biocept&#39;s equity offering pressures shares, down 36%\" data-tweet=\"$BIOC - Biocept&#39;s equity offering pressures shares, down 36% https://seekingalpha.com/news/3316671-biocepts-equity-offering-pressures-shares-down-36?source=tweet\" data-url=\"https://seekingalpha.com/news/3316671-biocepts-equity-offering-pressures-shares-down-36\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316660\" data-ts=\"1512576192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316660-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+78%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316660\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$MDGL $CLRB $VSAR-OLD - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3316660-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3316660-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316666\" data-ts=\"1512575717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEE\" target=\"_blank\">LEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316666-lee-enterprisesminus-3_1-print-ad-revenues-continue-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lee Enterprises -3.1% as print ad revenues continue decline</a></h4><ul>   <li>Lee Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/LEE' title='Lee Enterprises, Incorporated'>LEE</a>) is <font color='red'>off 3.1%</font> after <a href=\"https://seekingalpha.com/news/3316543-lee-misses-0_01\" target=\"_blank\">Q4 earnings</a> showed profits that improved but missed expectations on declining revenues.</li>    <li>EBITDA was down 1.1% to $36.7M (the best Y/Y change in EBITDA in two years).</li>    <li>Earnings were $3.5M, up from a year-ago $0.7M.</li>    <li>Digital ad revenue rose 6.1%, helped make up in part for a soft print ad environment. Subscription revenues were up 0.6% for the quarter.</li>    <li>Average daily newspaper circulation came to 0.8M; Sunday circulation was 1.1M.</li>    <li>Debt as of Sept. 24 is $548.4M after being reduced by $20.1M in the quarter and $68.8M in the fiscal year. Liquidity was $44.4M.</li>    <li><a href=\"https://seekingalpha.com/pr/17019480-lee-enterprises-reports-improved-financial-performance-fourth-quarter-2017-fiscal-year\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3316666\" data-linked=\"Lee Enterprises -3.1% as print ad revenues continue decline\" data-tweet=\"$LEE - Lee Enterprises -3.1% as print ad revenues continue decline https://seekingalpha.com/news/3316666-lee-enterprisesminus-3_1-print-ad-revenues-continue-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3316666-lee-enterprisesminus-3_1-print-ad-revenues-continue-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316664\" data-ts=\"1512574957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNP\" target=\"_blank\">SNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316664-reuters-sinopec-seeking-to-sell-nigeria-oil-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Sinopec seeking to sell its Nigeria oil business</a></h4><ul>     <li>Sinopec (<a href='https://seekingalpha.com/symbol/SNP' title='China Petroleum & Chemical Corporation'>SNP</a> <font color='red'>-1.8%</font>) has hired BNP&nbsp;Paribas to <a href=\"https://www.reuters.com/article/us-china-sinopec-divestiture-exclusive/exclusive-chinas-sinopec-looking-to-sell-nigeria-business-sources-idUSKBN1E01LN\" target=\"_blank\">sell its oil business in Nigeria and Gabon</a>, part of the Chinese company scaling back its presence in Africa, Reuters reports.</li>     <li>SNP spent $7.24B in 2009 for Switzerland-based Addax Petroleum, its largest ever foreign oil acquisition, to obtain land in Nigeria, Gabon, Cameroon and Iraq that was licensed for extraction and exploration, but it is now planning to sell Addax&rsquo;s onshore and offshore oil and gas production sites in Nigeria and Gabon, the report says; SNP&rsquo;s Cameroon operation would be its only remaining project in Africa.</li>     <li>The hunt for overseas assets was intended to bulk up energy reserves and meet future demand from China, but lower oil prices have made some of the investments unprofitable; also, China's economy has slowed a bit, and recent terror attacks on oil and gas facilities in Nigeria have further discouraged SNP.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316664\" data-linked=\"Reuters: Sinopec seeking to sell its Nigeria oil business\" data-tweet=\"$SNP - Reuters: Sinopec seeking to sell its Nigeria oil business https://seekingalpha.com/news/3316664-reuters-sinopec-seeking-to-sell-nigeria-oil-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3316664-reuters-sinopec-seeking-to-sell-nigeria-oil-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316662\" data-ts=\"1512574758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSIS\" target=\"_blank\">OSIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316662-osi-systemsminus-11_8-after-muddy-waters-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OSI Systems -11.8% after Muddy Waters report</a></h4><ul><li>        OSI Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSIS' title='OSI Systems, Inc.'>OSIS</a>) shares are&nbsp;<font color='red'>down 11.8%</font>&nbsp;after Muddy Waters Research <a href=\"http://muddywatersresearch.com/research/osis/mw-is-short-osis/\" target=\"_blank\">announces</a> a short position and calls the company &ldquo;rotten to the core.&rdquo;</li><li>               Muddy Waters questions how OSI obtained its Albania turnkey contract and the pricing of its major Mexico turnkey contract, which could fail to renew next year and have &ldquo;an enormous impact on OSIS&rsquo;s profits.&rdquo;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3304831-osi-systems-beats-0_08-beats-revenue\" target=\"_blank\">OSI Systems beats by $0.08, beats on revenue</a> (Oct. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316662\" data-linked=\"OSI Systems -11.8% after Muddy Waters report\" data-tweet=\"$OSIS - OSI Systems -11.8% after Muddy Waters report https://seekingalpha.com/news/3316662-osi-systemsminus-11_8-after-muddy-waters-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3316662-osi-systemsminus-11_8-after-muddy-waters-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316659\" data-ts=\"1512574265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLIR\" target=\"_blank\">CLIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316659-clearsign-wants-to-withdraw-sminus-1-statement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ClearSign wants to withdraw S-1 statement</a></h4><ul><li>           ClearSign (NASDAQ:<a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corp.'>CLIR</a>) <a href=\"https://seekingalpha.com/pr/17020017-clearsign-announces-request-withdraw-sminus-1-registration-statement\" target=\"_blank\">announces</a> submitting an SEC request to withdraw its S-1 statement. </li><li> The SEC hasn&rsquo;t declared the S-1 effective and no securities have been sold through the offering described in the statement. &nbsp; </li><li> \"In light of the recent stock price decline the company feels that it is in the best interests of shareholder value to withdraw the registration statement. Our board is continuing to go through a thorough review process to consider alternative funding and strategic options, and to pursue the best possible path for shareholders and the company,\" says CEO Stephen Pirnat. </li><li> ClearSign shares are&nbsp;<font color='green'>up 4%.</font>&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3310807-clearsign-combustion-reports-q3-results\" target=\"_blank\">Clearsign Combustion reports Q3 results</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316659\" data-linked=\"ClearSign wants to withdraw S-1 statement\" data-tweet=\"$CLIR - ClearSign wants to withdraw S-1 statement https://seekingalpha.com/news/3316659-clearsign-wants-to-withdraw-sminus-1-statement?source=tweet\" data-url=\"https://seekingalpha.com/news/3316659-clearsign-wants-to-withdraw-sminus-1-statement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316658\" data-ts=\"1512574251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316658-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories: </a>Crude <strong>-5.6M </strong>barrels vs. -3.4M consensus, -3.4M last week.</li><li>Gasoline <strong>+6.8M</strong> barrels vs. +1.7M consensus, +3.6M last week.</li><li>Distillates <strong>+1.7M</strong> barrels vs. +1.0M consensus, +2.7M last week.</li><li>Futures&nbsp;<font color='red'>-1.23%</font>&nbsp;to $56.91.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3316658\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3316658-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3316658-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316655\" data-ts=\"1512573950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316655-bank-of-canada-stays-on-hold-sounds-dovish-note-loonie-slides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank of Canada stays on hold, sounds dovish note; loonie slides</a></h4><ul><li>Not many were expecting the Bank of Canada to hike again today, but most anticipated at least some signaling toward a move at maybe the next meeting.</li><li>Instead: \"The Governing Council&nbsp;will continue to be cautious.\"</li><li><a href=\"https://www.bankofcanada.ca/2017/12/fad-press-release-2017-12-06/\" target=\"_blank\">Full statement</a></li><li>The loonie has tumbled more than 100 pips vs. the greenback, now buying $0.7840.</li><li>Stocks in Toronto are&nbsp;<font color='green'>up 0.15%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3316655\" data-linked=\"Bank of Canada stays on hold, sounds dovish note; loonie slides\" data-tweet=\"$EWC $FXC $CNDA - Bank of Canada stays on hold, sounds dovish note; loonie slides https://seekingalpha.com/news/3316655-bank-of-canada-stays-on-hold-sounds-dovish-note-loonie-slides?source=tweet\" data-url=\"https://seekingalpha.com/news/3316655-bank-of-canada-stays-on-hold-sounds-dovish-note-loonie-slides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316648\" data-ts=\"1512573946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316648-fda-accepts-insys-therapeutics-marketing-application-for-buprenorphine-sublingual-spray\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts INSYS Therapeutics&#39; marketing application for buprenorphine sublingual spray; shares down 2%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17020040-fda-accepts-new-drug-application-nda-buprenorphine-sublingual-spray-insys-therapeutics\" target=\"_blank\">accepts for review</a> INSYS Therapeutics' (<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-1.5%</font>)&nbsp;marketing application seeking approval for buprenorphine sublingual spray for the management of moderate-to-severe acute pain. The agency's action date is July 28, 2018.</li><li>The company says it plans to submit data from a 100-subject seven-day safety and tolerability study next quarter. If the agency determines that the additional data constitutes a major amendment to the filing, the action date may be extended another three months to late October.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316648\" data-linked=\"FDA accepts INSYS Therapeutics&#39; marketing application for buprenorphine sublingual spray; shares down 2%\" data-tweet=\"$INSY $INSYQ - FDA accepts INSYS Therapeutics&#39; marketing application for buprenorphine sublingual spray; shares down 2% https://seekingalpha.com/news/3316648-fda-accepts-insys-therapeutics-marketing-application-for-buprenorphine-sublingual-spray?source=tweet\" data-url=\"https://seekingalpha.com/news/3316648-fda-accepts-insys-therapeutics-marketing-application-for-buprenorphine-sublingual-spray\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316654\" data-ts=\"1512573882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316654-first-solar-extends-gains-after-investor-update-analysts-hike-price-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar extends gains after investor update; analysts hike price targets</a></h4><ul>     <li>First Solar (<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color='green'>+4.6%</font>) breaks out to fresh one-and-a-half-year highs in a strong response to <a href=\"https://seekingalpha.com/news/3316442-first-solar-plus-7-percent-unveils-first-functional-series-6-module-2018-guidance\" target=\"_blank\">yesterday's investor update</a>, which included above consensus 2018 earnings guidance and the rollout of its long-awaited Series 6 panel.</li>     <li>Analysts weigh in with several price target raises, with at least five sell-side shops coming out with praise for FSLR.</li>     <li>Guggenheim <a href=\"https://www.streetinsider.com/Analyst+Comments/First+Solar+%28FSLR%29+PT+Raised+to+%2474+at+Guggenheim+Following+Analyst+Day/13573279.html\" target=\"_blank\">hikes its FSLR target to $74</a> from $63, saying early success of Series 6 and favorable conditions in the marketplace encourage more ambitious expansion plans, and that the significant bookings help create visibility and improve conviction in its model estimates incrementally.</li>     <li>Needham says management's commitment to aggressive capacity expansion highlights the growing confidence in the large backlog of contracted business, and it believes FSLR's structural advantages position it to deliver solid top- and bottom-line growth beyond the 2018 transitional year (source:&nbsp;Briefing.com).</li>     <li>Other price target increases:&nbsp;Baird to $69 from $53, Cowen to $77 from $66, Deutsche Bank to $75 from $65.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316654\" data-linked=\"First Solar extends gains after investor update; analysts hike price targets\" data-tweet=\"$FSLR - First Solar extends gains after investor update; analysts hike price targets https://seekingalpha.com/news/3316654-first-solar-extends-gains-after-investor-update-analysts-hike-price-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3316654-first-solar-extends-gains-after-investor-update-analysts-hike-price-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316653\" data-ts=\"1512573849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316653-susquehanna-initiates-alibaba\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna initiates Alibaba</a></h4><ul><li>        Susquehanna <a href=\"https://www.cnbc.com/2017/12/06/stocks-making-the-biggest-moves-premarket-googl-fb-baba-avav-unh-hd-more.html\" target=\"_blank\">initiates</a> Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) with a Positive rating and $220 price target.</li><li>               The firm cites the &ldquo;impressive&rdquo; Taobao and Tmall retail platforms and says the ad businesses have &ldquo;ample runway ahead.&rdquo;&nbsp;</li><li>               Alibaba shares are&nbsp;<font color='green'>up 0.88%</font>. &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316540-ford-alibaba-set-tie-china\" target=\"_blank\">Ford, Alibaba set for tie-up in China</a> (Dec. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316653\" data-linked=\"Susquehanna initiates Alibaba\" data-tweet=\"$BABA - Susquehanna initiates Alibaba https://seekingalpha.com/news/3316653-susquehanna-initiates-alibaba?source=tweet\" data-url=\"https://seekingalpha.com/news/3316653-susquehanna-initiates-alibaba\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316649\" data-ts=\"1512572722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXM\" target=\"_blank\">OXM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316649-oxford-industriesplus-7-after-sizable-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oxford Industries +7% after sizable profit beat</a></h4><ul> <li>Shares of Oxford Industries (NYSE:<a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries Inc.'>OXM</a>) <font color='green'>race 7%</font> higher after the company almost doubled EPS estimates with its Q3 report.</li> <li>Gross margin rose 60 basis points to 53.7% of sales as increases in full price selling in the direct to consumer channels kicked in.</li> <li>The numbers from Oxford were strong enough to prompt Telsey Advisory Group to bump its price target up to $68 to $65.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3316459-oxford-industries-beats-0_05-misses-revenue\" target=\"_blank\">Oxford Industries beats by $0.05, misses on revenue</a> (Dec. 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316649\" data-linked=\"Oxford Industries +7% after sizable profit beat\" data-tweet=\"$OXM - Oxford Industries +7% after sizable profit beat https://seekingalpha.com/news/3316649-oxford-industriesplus-7-after-sizable-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3316649-oxford-industriesplus-7-after-sizable-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316647\" data-ts=\"1512572556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316647-amazon-prime-video-now-on-apple-tv-devices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon Prime Video now on Apple TV devices</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) <a href=\"https://seekingalpha.com/pr/17020021-amazon-prime-video-app-now-available-apple-tv-100-countries\" target=\"_blank\">announces</a> that its Prime Video app is now on available on Apple TV devices.</li><li>                  Prime Video for Apple TV was first announced over the summer.    </li><li>               Yesterday, Alphabet pulled YouTube from Amazon&rsquo;s Echo Show and Fire TV citing a lack of reciprocity since Amazon doesn&rsquo;t sell Alphabet&rsquo;s Chromecast or Nest devices.&nbsp;</li><li>Amazon shares are u<font color='green'>p 0.39%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316426-youtube-exiting-echo-show-fire-tv\" target=\"_blank\">YouTube exiting Echo Show, Fire TV</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316647\" data-linked=\"Amazon Prime Video now on Apple TV devices\" data-tweet=\"$AMZN - Amazon Prime Video now on Apple TV devices https://seekingalpha.com/news/3316647-amazon-prime-video-now-on-apple-tv-devices?source=tweet\" data-url=\"https://seekingalpha.com/news/3316647-amazon-prime-video-now-on-apple-tv-devices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316646\" data-ts=\"1512572420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316646-square-rolls-out-bitcoin-to-customers-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Square rolls out Bitcoin to more customers; shares up 5%</a></h4><ul><li>I<a href=\"https://twitter.com/CashApp/status/938224899604336647\" target=\"_blank\">n a tweet last night</a>, the company said it was rolling out Bitcoin to more of its most active customers. \"Swipe right from your Cash Card to see if you have it.\"</li><li><a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a> +5%</li><li>As for Bitcoin, it's now&nbsp;<font color='green'>up nearly 10%</font>&nbsp;for the day at a new record of $12,801.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316517-new-fed-nominee-fan-paper-money-bitcoin-tops-12k\" target=\"_blank\">New Fed nominee no fan of paper money; Bitcoin tops $12K</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316646\" data-linked=\"Square rolls out Bitcoin to more customers; shares up 5%\" data-tweet=\"$SQ - Square rolls out Bitcoin to more customers; shares up 5% https://seekingalpha.com/news/3316646-square-rolls-out-bitcoin-to-customers-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3316646-square-rolls-out-bitcoin-to-customers-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316642\" data-ts=\"1512571999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HQY\" target=\"_blank\">HQY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316642-healthequityminus-6_7-after-q3-beats-mixed-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HealthEquity -6.7% after Q3 beats, mixed guidance</a></h4><ul><li>        HealthEquity (NASDAQ:<a href='https://seekingalpha.com/symbol/HQY' title='HealthEquity'>HQY</a>) shares are&nbsp;<font color='red'>down 6.7%</font>&nbsp;after Q3 results beat EPS and revenue estimates but issued a mixed outlook.</li><li>                  Narrowed FY18 guidance: revenue, $225M to $228M (consensus: $227.06M, was: $223M to $228M); EPS, $0.64 to $0.66 (consensus: $0.71, was $0.64 to $0.68). &nbsp;   </li><li>               <a href=\"https://seekingalpha.com/pr/17019198-healthequity-reports-third-quarter-ended-october-31-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316458-healthequity-beats-0_04-beats-revenue\" target=\"_blank\">HealthEquity beats by $0.04, beats on revenue</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316642\" data-linked=\"HealthEquity -6.7% after Q3 beats, mixed guidance\" data-tweet=\"$HQY - HealthEquity -6.7% after Q3 beats, mixed guidance https://seekingalpha.com/news/3316642-healthequityminus-6_7-after-q3-beats-mixed-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3316642-healthequityminus-6_7-after-q3-beats-mixed-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316638\" data-ts=\"1512571345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTGN\" target=\"_blank\">VTGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316638-vistagen-nabs-u-s-patent-covering-lead-candidate-avminus-101-shares-ahead-95\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VistaGen nabs U.S. patent covering lead candidate AV-101; shares ahead 95%</a></h4><ul><li>The USPTO <a href=\"https://seekingalpha.com/pr/17020001-vistagen-therapeutics-granted-u-s-patent-regarding-methods-production-avminus-101\" target=\"_blank\">issues </a>Patent No. 9,834,801 to VistaGen Therapeutics (<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='green'>+94.6%</font>) covering certain production methods for lead candidate AV-101.</li><li><a href=\"http://www.vistagen.com/?page_id=11\" target=\"_blank\">AV-101</a>&nbsp;is an orally available central nervous system &#40;CNS&#41; prodrug that is converted in the brain by cells called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Astrocyte\" target=\"_blank\">astrocytes&nbsp;</a>into its active metabolite, 7-chlorokynurenic acid (7-CI-KYNA), a highly selective antagonist of certain receptors &#40;NMDA&#41;&nbsp;that play key roles in neurodegenerative diseases like epilepsy, MDD and neuropathic pain.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316638\" data-linked=\"VistaGen nabs U.S. patent covering lead candidate AV-101; shares ahead 95%\" data-tweet=\"$VTGN - VistaGen nabs U.S. patent covering lead candidate AV-101; shares ahead 95% https://seekingalpha.com/news/3316638-vistagen-nabs-u-s-patent-covering-lead-candidate-avminus-101-shares-ahead-95?source=tweet\" data-url=\"https://seekingalpha.com/news/3316638-vistagen-nabs-u-s-patent-covering-lead-candidate-avminus-101-shares-ahead-95\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316635\" data-ts=\"1512571110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LQDT\" target=\"_blank\">LQDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316635-liquidity-servicesminus-5_2-after-q4-misses-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liquidity Services -5.2% after Q4 misses, downside guidance</a></h4><ul><li>        Liquidity Services (NASDAQ:<a href='https://seekingalpha.com/symbol/LQDT' title='Liquidity Services, Inc.'>LQDT</a>) shares are&nbsp;<font color='red'>down 5.2%</font>&nbsp;after Q4 results missed EPS and revenue estimates.</li><li>               Q1 guidance has EPS from -$0.34 to -$0.25 compared to the -$0.16 consensus.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17019178-liquidity-services-announces-fourth-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316453-liquidity-services-misses-0_09-misses-revenue\" target=\"_blank\">Liquidity Services misses by $0.09, misses on revenue</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316635\" data-linked=\"Liquidity Services -5.2% after Q4 misses, downside guidance\" data-tweet=\"$LQDT - Liquidity Services -5.2% after Q4 misses, downside guidance https://seekingalpha.com/news/3316635-liquidity-servicesminus-5_2-after-q4-misses-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3316635-liquidity-servicesminus-5_2-after-q4-misses-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316632\" data-ts=\"1512570310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JUNO\" target=\"_blank\">JUNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316632-juno-inks-three-agreements-to-advance-program-in-multiple-myeloma-shares-ahead-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juno inks three agreements to advance program in multiple myeloma; shares ahead 4% premarket</a></h4><ul><li>Juno Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a>) is up&nbsp;<font color='green'>4%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17019904-juno-therapeutics-signs-licensing-agreements-lilly-oncotracker-fred-hutchinson-cancer\" target=\"_blank\">announcement </a>that it has consummated three contracts to support the advancement of its program in multiple myeloma &#40;MM&#41;&nbsp;using gamma secretase inhibitors (GSIs) in combination with BCMA-directed CAR T cells.</li><li>One of the agreements is with Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) for the rights to its GSI candidate LY3039478. Agreements with OncoTracker and Fred Hutchinson Cancer Research Center secured the rights to intellectual property related to combinations of GSIs and BCMA-directed engineered T cells.</li><li>Gamma secretase is an enzyme that cleaves a group of transmembrane proteins, including BCMA. Studies have shown that treatment with GSIs can increase the surface expression of BCMA on cancer cells, especially MM, which may boost the efficacy of BCMA-directed CAR T therapy.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316632\" data-linked=\"Juno inks three agreements to advance program in multiple myeloma; shares ahead 4% premarket\" data-tweet=\"$JUNO $JUNO $LLY - Juno inks three agreements to advance program in multiple myeloma; shares ahead 4% premarket https://seekingalpha.com/news/3316632-juno-inks-three-agreements-to-advance-program-in-multiple-myeloma-shares-ahead-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3316632-juno-inks-three-agreements-to-advance-program-in-multiple-myeloma-shares-ahead-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316630\" data-ts=\"1512570278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIVO\" target=\"_blank\">TIVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316630-tivo-ceo-buys-1m-in-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TiVo CEO buys $1M in shares</a></h4><ul>   <li>TiVo (NASDAQ:<a href='https://seekingalpha.com/symbol/TIVO' title='TiVo Inc.'>TIVO</a>) is <font color='green'>up 2.8%</font> premarket in thin trade after an <a href=\"https://seekingalpha.com/filing/3789179\" target=\"_blank\">SEC filing</a> shows its chief executive picking up almost a million dollars in shares.</li>    <li>President/CEO Enrique Rodriguez bought 55,974 shares across two transactions this week (54,054 at $17.8647, and 1,920 at $17.681), for a net outlay of $999,606.</li>    <li>Shares are <font color='red'>down 23%</font> YTD and have <font color='red'>fallen 9%</font> over the past couple of weeks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316630\" data-linked=\"TiVo CEO buys $1M in shares\" data-tweet=\"$TIVO - TiVo CEO buys $1M in shares https://seekingalpha.com/news/3316630-tivo-ceo-buys-1m-in-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3316630-tivo-ceo-buys-1m-in-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316628\" data-ts=\"1512569968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316628-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li>CLNT <font color='green'>+68%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3316616-cleantech-plus-60-percent-deal-enter-investment-management-business\" target=\"_blank\">deal</a> to enter investment management business.</li>     <li><a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+43%</font>&nbsp;as lead candidate <a href=\"https://seekingalpha.com/news/3316620-madrigal-pharmas-lead-candidate-successful-mid-stage-nash-study-shares-ahead-45-percent\" target=\"_blank\">successful</a> in mid-stage NASH study.</li>     <li><a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+36%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3316603-cellectar-bio-26-percent-premarket-expansion-mid-stage-study-clr-131\" target=\"_blank\">expansion</a> of mid-stage study of CLR 131.</li>     <li><a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+28%</font>&nbsp;on equity <a href=\"https://seekingalpha.com/news/3316485-viking-therapeutics-initiates-equity-offering\" target=\"_blank\">offering</a>.</li>     <li><a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a> <font color='green'>+22%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3316467-aerovironment-beats-0_35-beats-revenue\" target=\"_blank\">earning</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='green'>+16%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3316539-china-zenix-auto-reports-q3-results\" target=\"_blank\">earning</a>.</li>     <li><a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+12%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a> <font color='green'>+12%</font>&nbsp;to <a href=\"https://seekingalpha.com/news/3316562-unitedhealths-optum-acquire-davita-medical-group-davita-3-percent-premarket\" target=\"_blank\">acquire</a> DaVita Medical Group.</li>     <li><a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a> <font color='green'>+11%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a> <font color='green'>+11%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+6%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3316592-american-eagle-outfitters-misses-0_01-revenue-line\" target=\"_blank\">earning</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+5%&nbsp;</font>as HBV candidate ACR-520 shows <a href=\"https://seekingalpha.com/news/3316613-arrowhead-pharmas-hbv-candidate-acrminus-520-shows-positive-effect-mid-stage-study-shares-11\" target=\"_blank\">positive effect</a> in mid-stage study.</li>     <li><a href='https://seekingalpha.com/symbol/GLBL' title='TerraForm Global'>GLBL</a> <font color='green'>+5%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17019252-terraform-global-extends-termination-date-merger-agreement-march-6-2018\" target=\"_blank\">extending</a> the termination date under the Agreement and Plan of Merger entered into on March 6, 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316628\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$SEII $MDGL $CLRB - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3316628-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3316628-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316625\" data-ts=\"1512569773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316625-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='red'>-35%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17019715-biocept-announces-pricing-public-offering-4925-936-shares-common-stock\" target=\"_blank\">pricing</a> public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/PXS' title='Pyxis Tankers Inc.'>PXS</a> <font color='red'>-23%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17019853-pyxis-tankers-inc-announces-4_8-million-private-placement-common-stock\" target=\"_blank\">announcing</a> a $4.8M private placement of common stock.</li><li><a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a>&nbsp;<font color='red'>-21%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3316556-freds-eps-1_38\" target=\"_blank\">Q3 earnings.</a></li><li><a href='https://seekingalpha.com/symbol/TROX' title='Tronox Inc.'>TROX</a>&nbsp;<font color='red'>-21%</font>&nbsp;as FTC <a href=\"https://seekingalpha.com/news/3316595-tronox-fight-ftc-lawsuit-jpm-sees-standalone-value-16-without-cristal\" target=\"_blank\">challenges</a> proposed merger with Cristal.</li><li>BBG&nbsp;<font color='red'>-15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3316484-bill-barrett-merge-fifth-creek-energy-launch-21m-share-offering\" target=\"_blank\">announcing</a> merger with Fifth Creek Energy.</li><li><a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-11%</font>.</li><li><a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='red'>-10%</font>.</li><li><a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a>&nbsp;<font color='red'>-7%</font>&nbsp;after Goldman <a href=\"https://seekingalpha.com/news/3316591-chemours-minus-4_7-percent-goldman-downgrade\" target=\"_blank\">downgrade</a>.</li><li><a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/PDCO' title='Patterson Companies Inc.'>PDCO</a>&nbsp;<font color='red'>-6%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3316587-morgan-stanley-bearish-patterson-schein-amazon-threat\" target=\"_blank\">downgraded</a> by Morgan Stanley.</li><li><a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3316625\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$BIOC $PXS $FRED - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3316625-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3316625-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316622\" data-ts=\"1512569560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOMX\" target=\"_blank\">FOMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316622-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Foamix (NASDAQ:<a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals'>FOMX</a>) initiated with Buy rating and $8 (43% upside) price target by Guggenheim.</li><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) initiated with Buy rating and $42 (21% upside) price target by Guggenheim.</li><li>Dermira (NASDAQ:<a href='https://seekingalpha.com/symbol/DERM' title='Dermira'>DERM</a>) initiated with Buy rating and $30 (24% upside) price target by Guggenheim.</li><li>Express Scripts (NASDAQ:<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a>) upgraded to Market Perform by Bernstein.</li><li>Novo Nordisk (NYSE:<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a>) upgraded to Buy by BofAML.</li><li>Aetna (NYSE:<a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a>) downgraded to Hold by Argus.</li><li>Henry Schein and Patterson Companies downgraded to Underweight by Morgan Stanley on potential encroachment by Amazon.</li><li>Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) downgraded to Neutral by BofAML.</li><li>Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) downgraded to Underperform by BofAML.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3316622\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$FOMX $FOMX $RVNC - Premarket analyst action - healthcare https://seekingalpha.com/news/3316622-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3316622-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316621\" data-ts=\"1512569463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316621-evercore-isi-initiates-amazon-alphabet-and-facebook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore ISI initiates Amazon, Alphabet, and Facebook</a></h4><ul><li>        Evercore ISI <a href=\"https://www.cnbc.com/2017/12/06/facebook-will-lead-a-surge-in-tech-stocks-next-year-with-a-30-percent-gain-evercore-isi-says.html\" target=\"_blank\">initiates</a> Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>), Alphabet (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>), and Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) at Outperform.</li><li>               Analyst Anthony DiClemente writes, &ldquo;Today&rsquo;s leading tech companies are leveraging the internet to disrupt and take profits from established industries, a dynamic that is driving real earnings and free cash flow growth.&rdquo;&nbsp;</li><li>               DiClemente says Facebook&rsquo;s web traffic from 2013 to 2017 has &ldquo;grown five-fold to exceed 40 percent&rdquo; and notes Instagram&rsquo;s incredible growth.&nbsp;</li><li>               The analyst expresses optimism on Amazon&rsquo;s businesses from AWS to Alexa and Prime Instant Video.&nbsp;</li><li>               DiClemente expects Alphabet&rsquo;s Google to &ldquo;outpace&rdquo; search industry growth with a shift towards mobile.&nbsp;</li><li>               Price targets: Amazon, $1,350; Alphabet, $1,230; Facebook, $225.&nbsp;</li><li>               Amazon shares are<font color='red'> down 0.31%</font>&nbsp;premarket.&nbsp;</li><li>               Alphabet shares are&nbsp;<font color='red'>down 0.25%</font>.&nbsp;</li><li>               Facebook shares are&nbsp;<font color='red'>down 0.47%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3316621\" data-linked=\"Evercore ISI initiates Amazon, Alphabet, and Facebook\" data-tweet=\"$AMZN $AMZN $GOOGL - Evercore ISI initiates Amazon, Alphabet, and Facebook https://seekingalpha.com/news/3316621-evercore-isi-initiates-amazon-alphabet-and-facebook?source=tweet\" data-url=\"https://seekingalpha.com/news/3316621-evercore-isi-initiates-amazon-alphabet-and-facebook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316620\" data-ts=\"1512568946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGL\" target=\"_blank\">MDGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316620-madrigal-pharmas-lead-candidate-successful-in-mid-stage-nash-study-shares-ahead-45-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Madrigal Pharma&#39;s lead candidate successful in mid-stage NASH study; shares ahead 45% premarket</a></h4><ul><li>Thinly traded micro cap Madrigal Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a>) is up&nbsp;<font color='green'>45%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17019492-madrigal-s-mglminus-3196-achieves-primary-endpoint-patients-biopsy-proven-non-alcoholic\" target=\"_blank\">announcement</a> of positive results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02912260?term=mgl-3196&amp;rank=4\" target=\"_blank\">Phase 2 clinical trial</a> assessing lead candidate MGL-3196 in patients with biopsy-confirmed nonalcoholic steatohepatitis &#40;NASH&#41;.</li><li>The study met its primary endpoint of a statistically significant reduction in liver fat from baseline as measured by an non-invasive imaging test called MRI-PDFF. Specifically, the change from baseline in MRI-PDFF in the overall treatment group was -36.3% versus -9.6% for placebo (p&lt;0.0001).</li><li>The percentage of patients achieving at least a 30% reduction in liver fat was 60.3% compared to 18.4% for placebo (p&lt;0.0001). A 30% or more reduction in liver fat is associated with an improvement in NASH as determined by biopsy.</li><li>Significant improvements in liver enzymes and lipids were also observed.</li><li>MGL-3196's safety profile was favorable with most adverse events (AEs) considered mild. Three serious AEs were reported, none related to the study drug.</li><li>The trial is ongoing. Additional data will be assessed at week 36. The estimated study completion date is March 2018.</li><li><a href=\"http://www.madrigalpharma.com/home-page/pipeline/thr-beta-agonist/\" target=\"_blank\">MGL-3196</a>&nbsp;is&nbsp;a once-daily, orally available, liver-directed selective thyroid hormone receptor-beta agonist.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316620\" data-linked=\"Madrigal Pharma&#39;s lead candidate successful in mid-stage NASH study; shares ahead 45% premarket\" data-tweet=\"$MDGL - Madrigal Pharma&#39;s lead candidate successful in mid-stage NASH study; shares ahead 45% premarket https://seekingalpha.com/news/3316620-madrigal-pharmas-lead-candidate-successful-in-mid-stage-nash-study-shares-ahead-45-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3316620-madrigal-pharmas-lead-candidate-successful-in-mid-stage-nash-study-shares-ahead-45-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316617\" data-ts=\"1512568366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRA\" target=\"_blank\">VRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316617-vera-bradley-higher-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vera Bradley higher after earnings</a></h4><ul> <li>Vera Bradley (NASDAQ:<a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a>) jumps after topping some beaten-down Q3 EPS estimates and setting holiday quarter profit guidance ahead of estimates.</li> <li>Despite a 7.4% drop in comparable sales during Q3, the retailer fired off cost reductions that led to a gross margin rate of 56.8% vs. Vera's guidance range of 57.1% to 57.6%.</li> <li>Looking ahead, the company expects Q4 revenue of $127M to $132M and EPS of $0.30 to $0.33 vs. $0.30 consensus.</li> <li>Shares of Vera Bradley are <font color='green'>up 11%</font> in premarket trading</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316617\" data-linked=\"Vera Bradley higher after earnings\" data-tweet=\"$VRA - Vera Bradley higher after earnings https://seekingalpha.com/news/3316617-vera-bradley-higher-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3316617-vera-bradley-higher-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316616\" data-ts=\"1512568288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEII\" target=\"_blank\">SEII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316616-cleantechplus-60-on-deal-to-enter-investment-management-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleantech +60% on deal to enter investment management business</a></h4><ul>     <li>Cleantech Solutions (CLNT) <font color='green'>+60%</font> premarket on news it <a href=\"https://seekingalpha.com/pr/17019471-cleantech-solutions-international-enters-conditional-share-swap-agreement-ever-long-holdings\" target=\"_blank\">acquired a 51% interest</a> in the issued share capital of Brighten Holdings, a subsidiary of Hong Kong-listed Styland Holdings, through a conditional share swap agreement.</li>     <li>CLNT says Brighten is a boutique investment firm specializing in securitization, M&amp;A and direct investments into technology companies related to the sharing economy, O2O and finance technology.</li><li>CLNT says the deal \"opens some promising new growth areas for us as we explore innovative  technology and media acquisition opportunities, as well as opening up a  new investment management function in the group.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316616\" data-linked=\"Cleantech +60% on deal to enter investment management business\" data-tweet=\"$SEII - Cleantech +60% on deal to enter investment management business https://seekingalpha.com/news/3316616-cleantechplus-60-on-deal-to-enter-investment-management-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3316616-cleantechplus-60-on-deal-to-enter-investment-management-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316613\" data-ts=\"1512567809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316613-arrowhead-pharmas-hbv-candidate-acrminus-520-shows-positive-effect-in-mid-stage-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrowhead Pharma&#39;s HBV candidate ACR-520 shows positive effect in mid-stage study; shares up 11% premarket</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17019524-arrowhead-presents-new-clinical-data-demonstrating-sustained-host-response-hepatitis-b\" target=\"_blank\">New data</a> from a Phase 2 clinical trial, Heparc-2001, assessing Arrowhead Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a>) lead candidate ARC-520 in patients with chronic hepatitis B virus &#40;HBV&#41; infection showed a significant reduction in HBV surface antigen (HBsAg) seven months after the last dose. Specifically, HBsAg levels were reduced by a maximum of 100,000 copies/mL (5.0 log10) from baseline, just above the lower limit of quantitation.</li><li>The results were presented at the HEP DART meeting in Kona, HI. Development is ongoing.</li><li>ARC-520 is an RNAi therapeutic that intervenes upstream of the reverse transcription process where current standard-of-care nucleotide and nucleoside analogs act and is designed to silence the production of all HBV gene products.</li><li>Shares are up&nbsp;<font color='green'>11%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3222549-fda-places-clinical-hold-arrowheads-mid-stage-study-lead-product-candidate-hepatitis-b-e\" target=\"_blank\">FDA places clinical hold on Arrowhead's mid-stage study of lead product candidate in hepatitis B e antigen-positive patients</a> (Nov. 8, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316613\" data-linked=\"Arrowhead Pharma&#39;s HBV candidate ACR-520 shows positive effect in mid-stage study; shares up 11% premarket\" data-tweet=\"$ARWR - Arrowhead Pharma&#39;s HBV candidate ACR-520 shows positive effect in mid-stage study; shares up 11% premarket https://seekingalpha.com/news/3316613-arrowhead-pharmas-hbv-candidate-acrminus-520-shows-positive-effect-in-mid-stage-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3316613-arrowhead-pharmas-hbv-candidate-acrminus-520-shows-positive-effect-in-mid-stage-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316611\" data-ts=\"1512567376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IEC\" target=\"_blank\">IEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316611-iec-electronics-misses-0_05-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IEC Electronics misses by $0.05, misses on revenue</a></h4><ul><li>IEC Electronics (NYSEMKT:<a href='https://seekingalpha.com/symbol/IEC' title='IEC Electronics Corp'>IEC</a>): Q4 EPS of $0.07 <font color='red'>misses by $0.05</font>.</li><li>Revenue of $27.62M (-2.8% Y/Y) <font color='red'>misses by $1.13M</font>.</li><li>Shares <font color='green'>+4.27%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17019776-iec-announces-fiscal-2017-fourth-quarter-year-end-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3316611\" data-linked=\"IEC Electronics misses by $0.05, misses on revenue\" data-tweet=\"$IEC - IEC Electronics misses by $0.05, misses on revenue https://seekingalpha.com/news/3316611-iec-electronics-misses-0_05-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3316611-iec-electronics-misses-0_05-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316603\" data-ts=\"1512566948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316603-cellectar-bio-up-26-premarket-on-expansion-of-mid-stage-study-of-clr-131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio up 26% premarket on expansion of mid-stage study of CLR 131</a></h4><ul><li>Thinly traded nano cap Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) is up&nbsp;<font color='green'>26%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17019689-cellectar-announces-expansion-relapsed-refractory-multiple-myeloma-cohort-phase-2-trial-clr\" target=\"_blank\">announcement </a>that it will increase enrollment to ~40 subjects in the treatment-resistant multiple myeloma cohort in its <a href=\"https://clinicaltrials.gov/ct2/show/NCT02952508?term=NCT02952508&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> assessing lead candidate CLR 131. Preliminary data showed a clinically meaningful benefit in this group.</li><li>The primary endpoint is objective response rate at day 84.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316603\" data-linked=\"Cellectar Bio up 26% premarket on expansion of mid-stage study of CLR 131\" data-tweet=\"$CLRB - Cellectar Bio up 26% premarket on expansion of mid-stage study of CLR 131 https://seekingalpha.com/news/3316603-cellectar-bio-up-26-premarket-on-expansion-of-mid-stage-study-of-clr-131?source=tweet\" data-url=\"https://seekingalpha.com/news/3316603-cellectar-bio-up-26-premarket-on-expansion-of-mid-stage-study-of-clr-131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316600\" data-ts=\"1512566140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316600-no-date-for-apples-ireland-repayment-cook-expects-pulled-china-apps-to-return\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">No date for Apple&#39;s Ireland repayment; Cook expects pulled China apps to return</a></h4><ul><li>        Ireland <a href=\"https://www.reuters.com/article/us-eu-apple-tax/ireland-says-yet-to-agree-exact-date-for-apple-to-start-transferring-tax-funds-idUSKBN1E01KD?feedType=RSS&amp;feedName=technologyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FtechnologyNews+%28Reuters+Technology+News%29\" target=\"_blank\">says</a> there isn&rsquo;t an exact date for when Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) will start transferring its $15B in back taxes.</li><li>               Finance Minister Paschal Donohoe says he expects the transfer to start after the country finishes setting up the escrow account at the end of January.&nbsp; &nbsp;&nbsp;</li><li>               In other overseas news, CEO Tim Cook <a href=\"https://in.reuters.com/article/china-fortunteforum-apple/apples-cook-optimistic-that-apps-pulled-in-china-will-be-back-idINKBN1E00MS?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FINbusinessNews+%28News+%2F+IN+%2F+Business+News%29\" target=\"_blank\">says</a> he expects the apps removed from the China App Store earlier this year will be reinstated.&nbsp;</li><li>               Apple received criticism for pulling virtual private network and messaging apps from the Chinese store due to pressure from the country&rsquo;s regulators.&nbsp;</li><li>Apple shares are&nbsp;<font color='red'>down 0.55%</font>.&nbsp; &nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316325-apples-u-s-market-share-dropped-ahead-iphone-x\" target=\"_blank\">Apple's U.S. market share dropped ahead of iPhone X</a> (Dec. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316446-apple-acquires-podcast-search-company-unveils-new-ad-program\" target=\"_blank\">Apple acquires podcast search company, unveils new ad program</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316600\" data-linked=\"No date for Apple&#39;s Ireland repayment; Cook expects pulled China apps to return\" data-tweet=\"$AAPL - No date for Apple&#39;s Ireland repayment; Cook expects pulled China apps to return https://seekingalpha.com/news/3316600-no-date-for-apples-ireland-repayment-cook-expects-pulled-china-apps-to-return?source=tweet\" data-url=\"https://seekingalpha.com/news/3316600-no-date-for-apples-ireland-repayment-cook-expects-pulled-china-apps-to-return\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316599\" data-ts=\"1512565967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNKO\" target=\"_blank\">FNKO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316599-funko-higher-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Funko higher after earnings</a></h4><ul> <li>Funko (NASDAQ:<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a>) trades higher after <a href=\"https://seekingalpha.com/pr/17019200-funko-reports-third-quarter-2017-results\" target=\"_blank\">posting</a> its first earnings report since the consumer products seller's IPO.</li> <li>The company generated sales growth of 21% on a 27% jump in active properties. Gross margin rose 170 bps to 40.9% of sales. SG&amp;A expenses increased to 22.8% of sales vs. 15.8% a year ago.</li> <li>FNKO <font color='green'>+4.30%</font> premarket to $9.70. The IPO last month was priced at $12.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316463-funko-beats-revenue\" target=\"_blank\">Funko beats on revenue</a> (Dec. 5)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316599\" data-linked=\"Funko higher after earnings\" data-tweet=\"$FNKO - Funko higher after earnings https://seekingalpha.com/news/3316599-funko-higher-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3316599-funko-higher-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316598\" data-ts=\"1512565888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316598-american-eagle-outfitters-positive-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Eagle Outfitters positive post Q3 results</a></h4><ul><li>American Eagle Outfitters (NYSE:<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a>) reports comparable sales rose 3% in <a href=\"https://seekingalpha.com/pr/17019687-american-eagle-outfitters-reports-record-third-quarter-sales-comp-sales-increased-3-percent\" target=\"_blank\">Q3</a>.</li><li>Gross margin rate declined 120 bps to 39%, due to higher promotions and increased shipping costs associated with a strong digital business.</li><li>SG&amp;A expense rate improved 80 bps to 22.6%.</li><li>Adjusted operating margin rate fell 70 bps to 11.9%.</li><li>Merchandise inventory&nbsp;+8.4% Y/Y to $534.02M.</li><li>Store count +1 Q/Q to 1,058.</li><li><b>Q4 Guidance</b>: Comparable-store sales:&nbsp;increase in the mid-single digits; Diluted EPS: ~$0.42 to $0.44.</li><li><b>FY2017 Guidance</b>:&nbsp;Capex: $160M to $170M; Store count: 1,050 - 1,061.</li><li>AEO&nbsp;<font color='green'>+1.80%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3316598\" data-linked=\"American Eagle Outfitters positive post Q3 results\" data-tweet=\"$AEO - American Eagle Outfitters positive post Q3 results https://seekingalpha.com/news/3316598-american-eagle-outfitters-positive-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3316598-american-eagle-outfitters-positive-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316595\" data-ts=\"1512565574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROX\" target=\"_blank\">TROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316595-tronox-to-fight-ftc-lawsuit-jpm-sees-standalone-value-16-without-cristal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tronox to fight FTC lawsuit; JPM sees standalone value at $16 without Cristal</a></h4><ul>     <li>Tronox (NYSE:<a href='https://seekingalpha.com/symbol/TROX' title='Tronox Inc.'>TROX</a>) says it will \"<a href=\"https://seekingalpha.com/pr/17019370-tronox-vigorously-fight-ftc-lawsuit\" target=\"_blank\">vigorously fight</a>\" the Federal Trade Commission lawsuit seeking to <a href=\"https://seekingalpha.com/news/3316508-tronox-minus-10-percent-ftc-challenges-proposed-merger-cristal\" target=\"_blank\">block its proposed acquisition</a> of Cristal's titanium dioxide business; shares <font color='red'>-21%</font> premarket.</li>     <li>TROX says the FTC's complaint is based on an erroneous view of the global TiO2 market and a flawed analysis of the Cristal transaction.</li>     <li>J.P. Morgan analysts say TROX's most likely remedy for the FTC would divest of about half of Cristal&rsquo;s volume in its Ashtabula, Ohio, facility (source: Briefing.com).</li>     <li>TROX likely will trade in the middle of its $16/share standalone value and $30, or ~$23, as investors will have trouble figuring out the most likely outcome, with shares likely trading closer to $20 today, JPM says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3316595\" data-linked=\"Tronox to fight FTC lawsuit; JPM sees standalone value at $16 without Cristal\" data-tweet=\"$TROX - Tronox to fight FTC lawsuit; JPM sees standalone value at $16 without Cristal https://seekingalpha.com/news/3316595-tronox-to-fight-ftc-lawsuit-jpm-sees-standalone-value-16-without-cristal?source=tweet\" data-url=\"https://seekingalpha.com/news/3316595-tronox-to-fight-ftc-lawsuit-jpm-sees-standalone-value-16-without-cristal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316587\" data-ts=\"1512565273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDCO\" target=\"_blank\">PDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316587-morgan-stanley-bearish-on-patterson-and-schein-amazon-threat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley bearish on Patterson and Schein by Amazon threat</a></h4><ul><li>Dental products distributors Patterson Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/PDCO' title='Patterson Companies Inc.'>PDCO</a>) and Henry Schein (NASDAQ:<a href='https://seekingalpha.com/symbol/HSIC' title='Henry Schein, Inc.'>HSIC</a>) are down&nbsp;<font color='red'>4%</font>&nbsp;and&nbsp;<font color='red'>3%</font>, respectively, premarket on the heels of downgrades to Underweight by Morgan Stanley. Analyst Steve Beuchaw cites market softness and the looming entry of Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>).</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3316587\" data-linked=\"Morgan Stanley bearish on Patterson and Schein by Amazon threat\" data-tweet=\"$PDCO $PDCO $HSIC - Morgan Stanley bearish on Patterson and Schein by Amazon threat https://seekingalpha.com/news/3316587-morgan-stanley-bearish-on-patterson-and-schein-amazon-threat?source=tweet\" data-url=\"https://seekingalpha.com/news/3316587-morgan-stanley-bearish-on-patterson-and-schein-amazon-threat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316580\" data-ts=\"1512564664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOL\" target=\"_blank\">TOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316580-sell-side-mostly-looking-for-bounce-in-toll-brothers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side mostly looking for bounce in Toll Brothers</a></h4><ul><li>Toll Brothers (NYSE:<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a>)<font color='red'> tumbled more than 7%</font>&nbsp;yesterday following an earnings miss, but the sell-side is mostly defending, with a number of price target hikes.</li><li>Wells Fargo ups to $54, KBW to $50, and Oppenheimer to $53. Toll closed last night at $46.93.</li><li>KeyBanc is an exception, downgrading to Sector Weight.</li><li>Speaking on the earnings call, <a href=\"https://www.reuters.com/article/us-toll-brothers-tax-reform/toll-brothers-sees-no-change-in-buyer-behavior-due-to-tax-reform-idUSKBN1DZ2H6?utm_campaign=trueAnthem:+Trending+Content&amp;utm_content=5a2716e404d3017a5c732f38&amp;utm_medium=trueAnthem&amp;utm_source=twitter\" target=\"_blank\">CEO Douglas Yearley said</a> the company hasn't seen a change in buyers' behavior from looming tax reform (which could did the value of the mortgage interest deduction, particularly for the high-end homes Toll mostly builds).</li><li>Checking guidance, Toll expects sees revenues rising as much as 29% in fiscal 2018, but the adjusted gross margin of 24% would be slightly down from this year.</li><li>Shares&nbsp;<font color='green'>+0.25%&nbsp;</font>premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316239-toll-brothers-misses-0_02-misses-revenue\" target=\"_blank\">Toll Brothers misses by $0.02, misses on revenue</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3316580\" data-linked=\"Sell-side mostly looking for bounce in Toll Brothers\" data-tweet=\"$TOL - Sell-side mostly looking for bounce in Toll Brothers https://seekingalpha.com/news/3316580-sell-side-mostly-looking-for-bounce-in-toll-brothers?source=tweet\" data-url=\"https://seekingalpha.com/news/3316580-sell-side-mostly-looking-for-bounce-in-toll-brothers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316573\" data-ts=\"1512563979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UMC\" target=\"_blank\">UMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316573-micron-suing-umc-for-trade-secret-infringement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron suing UMC for trade secret infringement</a></h4><ul><li>        United Microelectronics (NYSE:<a href='https://seekingalpha.com/symbol/UMC' title='United Microelectronics Corporation'>UMC</a>) <a href=\"https://www.reuters.com/article/brief-umc-says-it-sued-by-micron-technol/brief-umc-says-it-sued-by-micron-technology-over-trade-secret-infringement-idUSH9N1O5009?feedType=RSS&amp;feedName=companyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FcompanyNews+%28News+%2F+US+%2F+Company+News%29\" target=\"_blank\">announces</a> that Micron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) filed a civil suit accusing UMC of trade secret infringement related to DRAM.</li><li>               UMC will appoint legal counsel and says it respects the IP rights of other companies and won&rsquo;t violate those rights.&nbsp;</li><li>               UMC shares are&nbsp;<font color='green'>up 0.39%&nbsp;</font>premarket.&nbsp;</li><li>               Micron shares are&nbsp;<font color='red'>down 0.87%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3316573\" data-linked=\"Micron suing UMC for trade secret infringement\" data-tweet=\"$UMC $UMC $MU - Micron suing UMC for trade secret infringement https://seekingalpha.com/news/3316573-micron-suing-umc-for-trade-secret-infringement?source=tweet\" data-url=\"https://seekingalpha.com/news/3316573-micron-suing-umc-for-trade-secret-infringement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3316568\" data-ts=\"1512563492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRHC\" target=\"_blank\">TRHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3316568-tabula-rasa-prices-sale-of-shares-of-common-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tabula Rasa prices sale of shares of common stock</a></h4><ul> <li>Tabula Rasa HealthCare (NASDAQ:<a href='https://seekingalpha.com/symbol/TRHC' title='Tabula Rasa HealthCare'>TRHC</a>) <a href=\"https://seekingalpha.com/pr/17019359-tabula-rasa-healthcare-announces-pricing-sale-shares-common-stock\" target=\"_blank\">prices</a> the previous public offering of shares of its common stock at a price of $27.50 per share.</li><li>Closing date is December 8.</li><li>Shares are down&nbsp;<font color='red'>2%</font>&nbsp;premarket on modest volume. Yesterday's close was $29.</li><li>Previously:&nbsp;<a href=\"https://seekingalpha.com/news/3316165-tabula-rasa-launches-equity-offering\" target=\"_blank\">Tabula Rasa launches equity offering</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3316568\" data-linked=\"Tabula Rasa prices sale of shares of common stock\" data-tweet=\"$TRHC - Tabula Rasa prices sale of shares of common stock https://seekingalpha.com/news/3316568-tabula-rasa-prices-sale-of-shares-of-common-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3316568-tabula-rasa-prices-sale-of-shares-of-common-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}